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ABSTRACT OF THE DISSERTATION
ANTI-QUORUM SENSING AGENTS FROM SOUTH FLORIDA MEDICINAL
PLANTS AND THEIR ATTENUATION OF PSEUDOMONAS AERUGINOSA
PATHOGENICITY
by
Allison L. Adonizio
Florida International University, 2008
Miami, Florida
Professor Kalai Mathee, Major Professor
With the difficulty in treating recalcitrant infections and the growing resistance to
antibiotics, new therapeutic modalities are becoming increasingly necessary. The
interruption of bacterial quorum sensing (QS), or cell-cell communication is known to
attenuate virulence, while limiting selective pressure toward resistance. This study
initiates an ethnobotanically-directed search for QS inhibiting agents in south Florida
medicinal plants. Fifty plants were screened for anti-QS activity using two biomonitor
strains, Chromobacterium violaceum and Agrobacterium tumefaciens. Of these plants, six
showed QS inhibition: Conocarpus erectus L. (Combretaceae), Chamaecyce hypericifolia
(L.) Millsp. (Euphorbiaceae), Callistemon viminalis (Sol.ex Gaertn.) G. Don (Myrtaceae),
Bucida burceras L. (Combretaceae), Tetrazygia bicolor (Mill.) Cogn. (Melastomataceae),
and Quercus virginiana Mill. (Fagaceae). These plants were further examined for their
effects on the QS system and virulence of Pseudomonas aeruginosa, an intractable
opportunistic

pathogen

responsible

for

morbidity

and

mortality

in

the

immunocompromised patient. C. erectus, B. buceras, and C. viminalis were found to

v

significantly inhibit multiple virulence factors and biofilm formation in this organism.
Each plant presented a distinct profile of effect on QS genes and signaling molecules,
suggesting varying modes of action. Virulence attenuation was observed with marginal
reduction of bacterial growth, suggesting quorum quenching mechanisms unrelated to
static or cidal effects. Extracts of these plants were also investigated for their effects on
P. aeruginosa killing of the nematode Caenorhabditis elegans. Results were evaluated in
both toxin-based and infection-based assays with P. aeruginosa strains PA01 and PA14.
Overall nematode mortality was reduced 50-90%. There was no indication of host
toxicity, suggesting the potential for further development as anti-infectives. Using lowpressure chromatography and HPLC, two stereoisomeric ellagitannins, vescalagin and
castalagin were isolated from an aqueous extract of C. erectus. Structures were confirmed
via mass spectrometry and NMR spectroscopy. Both ellagitannins were shown to
decrease signal production, QS gene expression, and virulence factor production in P.
aeruginosa. This study introduces a potentially new therapeutic direction for the
treatment of bacterial infections. In addition, this is the first report of vescalagin and
castalagin being isolated from C. erectus, and the first report of ellagitannin activity on
the QS system.
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Chapter 1

Introduction

1

1.1 Preface
The following introduction includes a review of the literature and provides the
reader with a background for the experimentation to follow. As this is a multidisciplinary project, a number of different fields and sub-fields are explored with
relevance to this dissertation, including ethnobotany, medicinal phytochemistry, and
quorum sensing as a target to attenuate bacterial virulence and disease. Attention is also
given to the nature of the model pathogen Pseudomonas aeruginosa, its mechanisms of
antibiotic resistance, and its behavior in an nematode infection model.

1.2 Ethnobotany and pharmacognosy: looking to the past for solutions of the
future
Before pharmacy there was forest, before pills there were potions.

The

emergence of medicine paralleled that of the human species, and as we evolved so did
our pharmacopoeia. Modernization of our society and concomitant advances in chemistry
promised better, stronger, safer, and more widely available drugs. However the overuse
of antibiotics began an escalating trend of resistance in many pathogenic organisms. In
effect, our diseases were evolving right along with us.
Although combinatorial and synthetic chemistry can provide us with some
solutions for disease, many medicinal compounds already exist in nature and are awaiting
discovery. Vascular plants are one of the largest and most diverse organismal groups with
tropical and sub-tropical regions affording a high species biodiversity (Gurevitch et al.,
2002). This high biological diversity is likely linked to a high chemical diversity,
allowing for the evolution of numerous toxic and bioactive plant chemicals.

2

Phytochemistry, however, is directed by more than sheer randomness. Plants
create specific compounds to serve needs such as reproduction and defense. Limited by
their immobility, plants must rely on wind, water, or animals for pollination.

The

availability and precision of the former being somewhat uncertain, plants have adapted
various chemical means of attracting animals. Anthocyanin-based pigments attract birds,
sweet smelling phenolic volatiles attract bees, and foul indoles and amines are perfect for
fly pollination (Gurevitch et al., 2002).
Plants have likely evolved toxic and bioactive compounds to protect against
herbivory and pathogen attack. (Balick & Cox, 1999; Gurevitch et al., 2002). Because
plants are sessle, they rely more heavily on chemical defenses than motile organisms. In
many cases, the link between a toxin and a medicine is dosage, and numerous plant
toxins have found their way into our modern pharmacopoeia. Foxglove, Digitalis spp., if
ingested, can cause convulsions, cerebral disturbances, bradycardia, and eventual death
(Lacassie et al., 2000). However, at the correct dosage, the cardiac glycosides, digoxin
and digitoxin, have proven effective in the treatment of atrial fibrillation and heart failure
(Bussey et al., 1988).

1.2.1 Advantages of a directed search
Taking into account the vast number of plants that exist, and their evolved
chemical diversity, one can see the basis for screening plants for medicinal compounds.
However, combining these inherent qualities of plants with the direction of thousands of
years of amassed traditional knowledge creates an even better venue in which to search
for new drugs.
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Most plants contain some sort of constitutive or inducible defense against
phytopathogens, but plants used medicinally may also contain chemical defenses specific
to human pathogens. In fact, the efficiency of an ethnobotanically-directed search to this
end has proven to be about 40% higher than that of a random search (Khafagi &
Dewedar, 2000).
The word ethnobotany, from the Greek ethnos ’people’, is defined as “the study
of the interactions between people and plants” (Harshberger, 1896). It is a scholarly
pursuit somewhere between science and anthropology devoted to documentation and
understanding of the traditional classification and uses of plants in different human
societies. Studies in ethnobotany have provided us with lists of potentially medicinal
plants, but rarely a knowledge of their chemical nature.
Pharmacognosy was a term introduced by C.A. Seydler, a German medical
student, in 1815, derived from the Greek pharmakon, or drug, and gnosis, knowledge
(Tyler et al., 1981). The field of pharmacognosy was borne of pharmacology due to the
need for a more comprehensive approach to drug discovery and understanding. Swiss
pharmacist Friedrich Flueckiger expounded upon this idea stating that pharmacognosy is
“the simultaneous application of various scientific disciplines with the object of acquiring
knowledge of drugs from every point of view” (Tyler et al., 1981) including botany,
microbiology, taxonomy, phytochemistry, medicinal chemistry, and toxicology. In this
sense it is not so much a “subfield” of pharmacology as it is a larger, more
comprehensive idea entirely. Today, the term pharmacognosy typically refers to the
pharmacology of natural products (As defined by the American Society for
Pharmagognosy www.phcog.org). The combination of ethnobotany and pharmacognosy
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opens up an avenue of research into the potential drug applications of traditionally used
plants, often referred to as ethnopharmacology or ethnopharmacognosy.

1.2.2 Linking traditional and modern medicine
Ethnopharmacology puts drug discovery in a cultural construct. Making the link
back to a cultural use is beneficial for a number of reasons, both to traditional and
modern societies. Knowing the traditional use of a plant can guide drug discovery, by
giving chemists and biologists an idea of its potential use in modern society.

For

instance, plants used as snakebite remedies may be useful in finding antihypertensive
drugs. If one wants to survive the bite of a venomous snake, it is advantageous to lower
the blood pressure and slow the heart rate so as to not spread the poison to vulnerable
organs before it can be metabolized. This led to the discovery of antihypertensive
alkaloids in Rauvolfia spp. (often R. serpentina (L.) Benth. ex. Kurz), a small shrub in the
Apocynaceae (Dewick, 2002).
However, ethnopharmacology is not so myopic as to focus solely on the profit of
developed countries. Much of the work done in this field benefits traditional societies.
The documentation and preservation of indigenous pharmacopeias and healing
techniques, is becoming increasingly important with modernization and migration of
cultures. In addition, validation through modern scientific methods may help improve
healthcare in rural areas. The ideal ethnopharmacological study would begin with the
cultural anthropology of a particular group and their medical system in the context of that
culture, and include the documentation of indigenous medical knowledge to prevent loss
of information in future generations. There would have to be a botanical, chemical, and
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pharmacological workup of the plants to potentially derive useful and unique medicinal
compounds.

Each of these areas (anthropology, botany/taxonomy, chemistry,

pharmacology) could take years to fully explore. Consequently, most studies focus on
one aspect of ethnopharmacology, depending on the expertise and/or interests of the
researcher.

1.2.3 The ecology and ethnobotany of southern Florida
Southern Florida has a unique diversity of species due to its location between
tropical and temperate climates. This subtropical ecosystem is host to over 1600 native
and naturalized plants from various regions (Wunderlin, 1982; Wunderlin & Hansen,
2006). The diverse ecotypes of Miami-Dade County include coastal environments, scrub
and tropical dry forests, and pine rocklands, each with its own distinct cohort of species.
Plants in this region have provided important sources of food, timber, and
medicines for Native Americans and early European settlers. Despite the fact that they
lived along the coasts, the original inhabitants of modern-day Florida were dubbed the
“Glades Indians” by archaeologists (Goggin & Sturtevant, 1964). They segregated into a
number of distinct tribes including the Calusa, Tequesta, Mayaimi, and Jaega tribes of
southern Florida (McGoun, 1993) (Figure 1.1).
In the 17th and 18th centuries, the indigenous people of south Florida increased not
only their plant knowledge, but presumably their physical pharmacopoeia by trading with
nearby Cuban, Mexican, and Caribbean cultures. Advances in transportation led to
increased dissemination and accumulation of both knowledge and plant material. Plant
uses and the plants themselves moved into the area from lands as far as Central and South
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America and Africa (Austin, 1997). However, by the mid-18th century, European slavery
and disease had decimated the once powerful Glades peoples, and by 1763 all of
Florida’s pre-Columbian cultures were extinct (Milanich, 1995).

Figure 1.1 The tribal and geographical segregations of the Glades peoples in Florida.
Florida Museum of Natural History. Used with permission.

In the 17th and 18th centuries, the indigenous people of south Florida increased not
only their plant knowledge, but presumably their physical pharmacopoeia by trading with
nearby Cuban, Mexican, and Caribbean cultures. Advances in transportation led to
increased dissemination and accumulation of both knowledge and plant material. Plant
uses and the plants themselves moved into the area from lands as far as Central and South
America and Africa (Austin, 1997). However, by the mid-18th century, European slavery
and disease had decimated the once powerful Glades peoples, and by 1763 all of
Florida’s pre-Columbian cultures were extinct (Milanich, 1995).
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Although most estimates suggest roughly 20% of any native flora to be used by its
inhabitants, sadly only about 3% of the flora of southern Florida has been documented as
initially utilized by the Glades peoples, and approximately 10% by later inhabitants of the
region (Austin, 1997; Austin, 2004). However more data about medicinal use can be
pieced together from the ethnobotany of other cultures within the growth habitat of the
plant. For instance, while historical usage of buttonwood, Conocarpus erectus
(Combretaceae) is mainly confined to timber or fuel use in Florida; cultures from
Mexico, South America, the Caribbean, and Africa use this tree as a tonic, febrifuge, and
to treat various bacterial conditions (Austin, 1997; Burkhill, 1985; Melendez, 1982;
Morton, 1981).
Under the guidance of traditional knowledge, many plants have been discovered
to be useful in our modern system of medicine. Notable medicinal plants of southern
Florida include saw palmetto and the Madagascar periwinkle. Saw palmetto, Seranoa
repens (Aracaceae), is perhaps the most well-known plant from this region used in the
treatment of benign prostatic hyperplasia (Bennett et al., 2002; Madersbacher et al.,
2007). Whereas, the naturalized periwinkle Catharanthus roseus (Apocynaceae),
produces vinca-alkaloids used in the treatment of cancer (Heijden et al., 2004).
Although the plants chosen for this study are not a cohesive group of native
species used by one particular indigenous culture, they have a long history of medicinal
use throughout their native and naturalized range (Burkhill, 1985; Duke, 1972; Duke,
1985; Duke, 2000; Liogier, 1990; Morton, 1981). Additionally, all plants chosen have
been used historically to treat conditions such as wounds, infections, respiratory
conditions, and diarrhea – conditions potentially caused or complicated by bacteria.
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1.3 Botanicals as anti-bacterial therapies
There have been many ethnobotanically-directed searches for antibacterials,
demonstrating not only the need for these drugs, but also the large number of plant
species utilized for bacterial conditions especially in the tropics (Camporese et al., 2003;
Cowan, 1999; Gnanamani et al., 2003; Hernandez et al., 2003). Although medicinal plant
research has led to the discovery of many important medicines such as morphine
(Benyhe, 1994), quinine (Kremsner et al., 1994), paclitaxel (Wani et al., 1971), and
camptothecin (Wall et al., 1966), there is not a large degree of overlap between
commonly used plant medicines and antimicrobials in developed countries. However,
there are a few notable plants that have made their way to the drugstore shelves.

1.3.1 Tea tree oil
Melaleuca alternifolia Cheel (Myrtaceae), or tea tree, is a aromatic tree native to
Australia. The essential oil of M. alternifolia is a common topical antimicrobial agent. Its
antimicrobial activity has been attributed to terpinen-4-ol, the major monoterpenoid
component of the oil (Figure 1.2) (Carson & Riley, 1995). Other terpene constituents
include

γ-terpinene,

α-terpineol,

cineole,

and

p-cymene

(Dewick,

2002).

Monoterpenoids are composed of two isoprene units and occur widely in plants with
volatile oils such as those in the Lamiaceae, Myrtaceae, and Rutaceae. These compounds
tend to cause membrane disruption in bacteria (Cowan, 1999), and in addition account for
much of the aroma of a plant.
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Figure 1.2 α-Terpinol, a major monoterpene component of M. alternifolia
(http://en.wikipedia.org/wiki/Image:Terpineol_alpha.svg)

Tea tree oil has been proven in several in vitro (Hammer et al., 1996; Messager et
al., 2005), and topical studies (Carson et al., 1998; Satchell et al., 2002) to be
antibacterial and antifungal. It is effective against Staphylococcus aureus, Acinetobacter
baumannii, Escherichia coli and Pseudomonas aeruginosa, at a 5% concentration in hand
wash (Messager et al., 2005). It is also active against multi-drug resistant strains of S.
aureus (Halcon & Milkus, 2004; Park et al., 2007).

1.3.2 Oregano oil
Origanum vulgare L. (Lamiaceae) is a common herb native to Europe and the
Mediterranean. The essential oil fraction of O. vulgare is especially effective against
bacterial and fungal infections, of the gastrointestinal and genitourinary tract (Adam et
al., 1998; Blumenthal et al., 2000; Chun et al., 2005; Salgueiro et al., 2003). Its
antimicrobial activity is attributed to the phenolic monoterpenoids, carvacrol and thymol,
along with a number of other terpene alcohols, phenols, and sesquiterpenes (Rodrigues et
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al., 2004). The two main chemotypes of O. vulgare show either high thymol or high
carvacrol content (Figure 1.3) (Rodrigues et al., 2004). Both thymol and carvacrol are
antimicrobial (Cowan, 1999), however the latter is considered more effective (Chami et
al., 2004).

(a)

(b)

Figure 1.3 Two phenolic terpenoids of O. vulgare. (a) Thymol. (b) Carvacrol.
(http://en.wikipedia.org/wiki/Image:Thymol.png and http://en.wikipedia.org/wiki/Image:
Carvracol.png )

Oil of oregano has pronounced antifungal effect in vitro (Adam et al., 1998)
against a number of dermatophytes.

It also shows antibacterial activity against

Helicobacter pylori, a causative agent of gastric ulcers (Chun et al., 2005), and a number
of clinically-isolated pathogens including Haemophyllus influenzae, Staphylococcus
aureus, Escherichia coli, Streptococcus pneumoniae, and Enterobacter cloacae (HerschMartinez et al., 2005). Though most related to its prescribed use is its marked effect in
vitro and in a rat model against C. albicans (Chami et al., 2004; Salgueiro et al., 2003).
The antimicrobial effect is due to membrane disruption (Chami et al., 2004; Cowan,
1999).
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1.3.3 Myrrh
Myrrh is a fragrant, oleo-gum resin of various Commiphora Jacq. species in the
Buseraceae, a family consisting mainly of trees with aromatic, peeling bark (Judd et al.,
2002). Commiphora trees are native to parts of Africa, Asia, India, and the Middle East,
where the bark is scored to collect the resin (Blumenthal et al., 2000). Myrrh has a long
history of religious and medicinal use with references in Jewish, Muslim, and Christian
texts (Blumenthal et al., 2000; Cowan, 1999). It still sees use today in religious settings,
but is more commonly found in mouthwashes and toothpastes due to its antimicrobial
properties.
Myrrh consists of approximately 30-60% water soluble gum, 20-40% alcohol
soluble resin, and 8% volatile oil (Blumenthal et al., 2000). The volatile oil fraction
contains antimicrobial monoterpenes such as myrcene and α-camphorine, however
antimicrobial activity is also attributed to furanosesesquiterpenes (Figure 1.4)
(Blumenthal et al., 2000).

Figure 1.4 8-methoxyfuranodiene, a furanosesquiterpene of Commiphora species.
(Redrawn from http://chembiofinder.cambridgesoft.com)
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The antibacterial activity of Commiphora mulkul (synonym of Commiphora
wightii (Arn.) Bhandari) has been tested in vitro against a number of Gram positive and
Gram negative organisms and was found equal to that of kanamycin (Asif Saeed & Sabir,
2004).

The German commission E recognizes myrrh as an antibacterial and anti-

inflammatory.

It is approved for topical treatment of wounds, and for oral and

pharayngeal mucosa as a mouthwash (Blumenthal et al., 2000).

1.3.4 Untapped potential for antimicrobial activity
As mentioned previously, plants should be a great source of antimicrobial
compounds due to their environment. However, in comparison with other organisms,
plants do not have the monopoly on medicinal compounds especially in the case of
antimicrobials.

In fact, 75% of the modern antibiotics are derived from the

actinomycetes, a specific group of Gram-positive bacteria (Mendez & Salas, 2001).
Regardless, there are a few reasons why this should not deter one from screening plants
for antimicrobial compounds.
Antibiotic-producing microbes possess genes which protect them from the toxic
effects of these compounds. It is very easy for one microbe to acquire antibiotic
resistance from another through plasmid transfer or transposons. Plants, on the other
hand, are genetically dissimilar from the organisms they are trying to eradicate. Thus,
there is little chance for a microbe to gain resistance from a plant.
Plants can produce a multitude of diverse antimicrobial compounds such as
simple phenolics, catechins, quinones, flavanones, polyphenolics, alkaloids, and
terpenoids (Cowan, 1999; Dewick, 2002). Like microbial antibiotics, these compounds
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are targeted at killing the pathogen and work via a non-species specific mechanism such
as disrupting microbial cell membranes (Cowan, 1999).

However, it was recently

discovered that plants have another way of dealing with microbes - targeting a cell’s
communication system (Bauer, 2001).

One form of intercellular communication in

bacteria has been studied since the 1970’s, and is known as quorum sensing (for a review
see (Schauder & Bassler, 2001). Breakdown of this system causes an attenuation of
microbial pathogenicity (Finch et al., 1998; Smith & Iglewski, 2003b; Wu et al., 2004).
The discovery of anti-quorum sensing agents in plants provides us with yet another type
of “antimicrobial” agent.

1.4 Quorum sensing: a novel target
Quorum sensing (QS) is a population-dependent phenomenon first characterized
in the 1970s in luminescent marine species of Vibrio (Nealson et al., 1970). The ability
to sense the size of a bacterial population is mediated through small signaling molecules
or autoinducers (Hastings & Greenberg, 1999; Schauder & Bassler, 2001).

These

molecules are constantly produced and received at a basal level by bacterial cells. With
high population density, there is a surplus of signaling molecules in the environment.
These signals diffuse back into the cell where they facilitate the regulation of gene
expression (Hastings & Greenberg, 1999). QS systems are ubiquitous among bacteria,
and have since been found to regulate diverse functions such as luminescence, biofilm
formation, antibiotic and virulence factor generation, pigment production, plant-microbe
interactions, and motility (Hentzer et al., 2003; McClean et al., 1997; Rasmussen et al.,
2000; Rodelas et al., 1999; Shih & Huang, 2002).
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Although there are a number of different QS systems (Henke & Bassler, 2004),
the most widely studied paradigm is based on the Lux system of Vibrio fisheri and V.
harveyi

(Bassler et al., 1993; Stevens & Greenberg, 1997). This QS phenomenon

involves a three component-system: a freely diffusible signal, a synthetase to make this
signal, and a regulator that interacts in conjunction with the signal to regulate gene
expression. The main signaling molecules produced by Gram-negative bacteria are acylhomoserine lactones (AHLs) (Fuqua & Greenberg, 1998). They differ in the length of
their side chains and substitution at the C3 carbon, based on the organism that produces
them (Marketon et al., 2002; Whitehead et al., 2001a). (Figure 1.5)

Figure 1.5 Some of the various structures of AHLs, the main signaling molecule of
Gram negative bacteria. Length of the hydrocarbon side chain can range from C4 to C18,
and the C3 carbon may be substituted with an oxygen or hydroxyl group (modified from
(Whitehead et al., 2001a).
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In V. fisheri, LuxI produces an AHL signaling molecule which binds to LuxR at a
certain concentration (Stevens & Greenberg, 1997). This concentration is reached only
when enough bacteria are present (a quorum) to produce sufficient quantities of the AHL.
The V. fischeri LuxR-AHL complex can then bind to the operator and upregulate
transcription of the luciferase genes. (Figure 1.6)

Figure 1.6 The LuxI/R paradigm. LuxI is produced at a basal level in the cell which
synthesizes AHLs (red pentagons). The AHLs bind to LuxR (product of luxR) at a
certain concentration and activate transcription of luxI and the luciferase genes (Henke &
Bassler, 2004). Used with permission.

AHL-mediated quorum sensing systems based on the LuxI/R paradigm have been
characterized in human pathogens such as Pseudomonas aeruginosa (Pesci et al., 1997),
Yersinia pseudotuberculosis (Atkinson et al., 1999), and Escherichia coli (Surette &
Bassler, 1998), as well as plant associated bacteria such as Rhizobium leguminosarum
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(Rodelas et al., 1999), Ralstonia solanacearum, and Erwinia carotovora (Von Bodman et
al., 2003). In all cases these systems can regulate virulence. Thus, the discovery of QS
has given us a new target - a new way to attack and attenuate bacterial pathogenicity.

1.4.1 Anti-quorum sensing
The subsequent discovery of compounds that inhibit cell-to-cell communication,
dubbed anti-quorum sensing (anti-QS) agents could provide a novel method of combating
infection (Hentzer & Givskov, 2003a; Smith & Iglewski, 2003c).
Anti-QS agents were first characterized in the red marine alga, Delisea pulchura
(Manefield et al., 1999). This alga was investigated for its anti-fouling properties, and
was found to contain halogenated furanones, compounds which block AHLs via
competitive inhibition and destabilization of LuxR (Figure 1.7) (Manefield et al., 2002).

(a)

(b)

Figure 1.7 Comparison of AHL (a) and halogenated furanone (b). The structural
similarity allows furanones to competitively inhibit the action of AHL signaling
molecules. (AHL redrawn from http://chembiofinder.cambridgesoft.com, furanone
redrawn from (Manefield et al., 2002))
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Delisea furanones have been shown to reduce light emission in Vibrio species
(Givskov et al., 1996), inhibit pigment production in C. violaceum (Martinelli et al.,
2004) and attenuate exoenzyme production and swarming motility in Serratia
liquefaciens (Rasmussen et al., 2000). Both natural and synthetic derivatives of Delisea
furanones have also been shown to attenuate P. aeruginosa infection in vitro and in a
murine model (Hentzer et al., 2003; Wu et al., 2004).
Since the discovery of AHL inhibitors in D. pulchura, anti-QS activity has been
found in a south Florida Caulerpa species (Willsie, 2000) and a number of higher plants
including various fruits and vegetables (Rasmussen et al., 2005; Teplitski et al., 2000;
Vattem et al., 2007).
Pisum sativum (pea) seedlings and root exudates produced an inhibition of
pigment production, exochitinase activity, and protease activity in C. violaceum
(Teplitski et al., 2000). Some fractionation of the crude extract was attempted, however,
no active compounds were purified.
Garlic (Allium sativum), carrot (Daucus carota), chamomile (Matricaria sp.),
water lily (Nymphaea sp.) and various peppers (Capsicum spp.) were found to possess
anti-QS activity against a luxI-gfp reporter strain (Rasmussen et al., 2005). Garlic was
also found to inhibit biofilm formation in P. aeruginosa, and prevented nematode death
in a limited analysis (Rasmussen et al., 2005). Garlic extract was partially fractionated in
this study, but again, no purified compounds were elucidated.
Various fruits and herbs were recently shown to possess anti-QS activity in a C.
violaceum biomonitor strain and on the swarming motility of E. coli and P. aeruginosa
(Vattem et al., 2007). Fruits including raspberry, blueberry, blackberry, cranberry, and
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grape, and herbs such as thyme, ginger, basil, kale, oregano and turmeric exhibited
moderate inhibition of these QS-controlled processes. However, no data was obtained in
a live animal model, nor were active compounds purified from the extracts. The latter two
studies were published after the publication of the initial work in this dissertation,
indicating an increasing trend in this area of research.
Other than signal mimics such as the furanones and synthetic derivatives, the
compounds ellagic acid, tannic acid, and epigallocatechin gallate have been shown to
inhibit QS in both an E. coli and a P. aeruginosa biomonitor strain (Huber et al., 2004).
These and related polyphenolics are widespread throughout the plant kingdom and should
be further explored as anti-QS compounds.

1.4.1.1 Mechanisms of QS inhibition
There are a number of ways to inhibit cell-cell communication (Figure 1.8)
including competitive inhibition, signal binding, degradation of the signaling molecule,
and inhibition of upstream precursors or genetic regulation systems.
Success has been seen with competitive inhibition in the case of the furanones,
(Figure 1.8b) however, many other QS antagonists have since been discovered (Kline et
al., 1999; Smith et al., 2003). These antagonists are based on the C12-AHL structure and
cause a reduction in LasR activity.
AHL-antibodies have also been developed to suppress QS through signal binding
(Figure 1.8c) (Debler et al., 2007; Smith & Iglewski, 2003b). A C12-AHL–protein
conjugate was able to sucessfully inhibit lasB expression (Smith and Iglewski
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unpublished data), and a similar molecule with extremely high binding affinity for C12AHL was recently crystallized and characterized (Debler et al., 2007).
Blocking S-adenosyl methionine (SAM) or the fatty acid precursors necessary to
synthesize AHLs leads to decreased production of C12-AHL by LasI (Figure 1.8e)
(Hoang et al., 2002). Of course genetic modification of upstream global regulators such
as Vfr and GacA has also been shown to greatly reduce QS activity and the subsequent
production of virulence factors (Albus et al., 1997; Reimmann et al., 1997).

Figure 1.8 Some potential targets of anti-QS compounds (Smith & Iglewski, 2003a).
The P. aeruginosa QS system is shown in (a). Inhibition may occur via competitive
inhibition by an AHL mimic (b), sequestration of the AHL signal (c), signal degradation
by lactonases (d) or acylaces (not shown), inhibition of AHL synthesis (e), blocking of
upstream regulation (f), and interference by antisense RNA (g).Used with permission.
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Scientists certainly do not have the monopoly on quorum inhibition. Numerous
bacteria including Bacillus sp., Variovorax paradoxus, Arthrobacter sp., and A.
tumefaciens produce lactonases – enzymes that cleave and deactivate the lactone ring of
various AHLs (Carlier et al., 2003; Dong et al., 2002; Leadbetter & Greenberg, 2000;
Park et al., 2003) (Figure 1.8d). Lactonase expression in P. aeruginosa, results in a
significant decrease in AHL production and virulence factor expression (Reimmann et
al., 2002).
Interest is growing in practical applications of anti-QS especially when faced with
increased incidence of drug failure due to the large number of pathogenic bacteria
developing resistance to available antibiotics. It has been suggested that targeting
pathogenesis instead of killing the organism may provide less selective pressure and
therefore decreased emergence of resistant strains (Hentzer & Givskov, 2003b;
Whitehead et al., 2001b).

1.5 Model organism: Pseudomonas aeruginosa
Pseudomonas aeruginosa is a Gram-negative, aerobic bacillus, with length and
width ranging from 1.5-3.0 μm and 0.5-0.8 μm respectively (Figure 1.9) (Bergey, 2001).
It is motile by means of a single polar flagella, and is an oxidase-positive, nonsporulating and non-fermentative species (Bergey, 2001). Other diagnostic characteristics
include beta-hemolysis of blood agar, pigment production - including pyocyanin (bluegreen), pyoverdin (yellow-green), and pyorubin (red-brown), and a distinct grape-like
odor (Bergey, 2001). It is a ubiquitous organism with the ability to colonize diverse
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niches due to its range of metabolic capabilities and resistance to environmental
challenges. (Vasil, 1986).

Figure 1.9 Multiple views of Pseudomonas aeruginosa. From L to R: Scanning electron
microscopy, false-color microscopy, colonies on agar, gram stained cells.
(http://upload.wikimedia.org/wikipedia/commons/thumb/c/cf/Pseudomonas_aeruginosa_
SEM.jpg;http://www.bact.wisc.edu/themicrobialworld/nfP.aeruginosa_colonies.jpg,http:/
/news.bbc.co.uk/olmedia/1745000/images/_1746739_pseudomonas_aeruginosa300.jpg
http://www.pseudomonas.com/images/paeruginosa.jpg)

1.5.1 Virulence factors and toxins
Contributing to the pathogenicity of P. aeruginosa are a multitude of secreted
toxins and virulence factors including, phospholipase C, rhamnolipid, superoxide
dismutase, HCN, exotoxin A, exoenzyme, pyocyanin, pyoverdin, LasA protease and
LasB elastase (Baker, 1982; Bever & Iglewski, 1988; Coburn, 1992; Doring et al., 1987;
Edwards & Hayashi, 1965; Lau et al., 2004; Meyer et al., 1996; Stinson & Hayden,
1979). Many of these factors cause or catalyze reactions in the host leading to cell death
and tissue necrosis, however the latter three factors are focused on this study.
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Pyoverdin, a yellow-green florescent pigment produced by P. aeruginosa,
competes with mammalian transferrin for iron, the successful sequestration of which
essentially starves the host tissues (Meyer et al., 1996). It also promotes pathogenicity by
stimulating bacterial growth (Cox & Adams, 1985).
LasA and LasB are zinc metalloendopeptidases of 20-kDa and 33-kDa
respectively, belonging to the β-lytic endopeptidase family of proteases (Toder et al.,
1994). LasA has a limited substrate specificity as compared to LasB, however they
operate in conjunction to degrade elastin, a key component in tissue plasticity. LasA
nicks elastin allowing it to be cleaved by LasB and other proteases. Working together
these proteases are capable of destroying or inactivating a wide range of biological
tissues and immunological agents (Bever & Iglewski, 1988; Kessler et al., 1993).

1.5.2 Pseudomonas aeruginosa disease association
Due to its arsenal of virulence factors and the tendency to form intractable
biofilms (discussed later in this section), P. aeruginosa is not surprisingly one of the
leading organisms implicated in nosocomial infections. According to a detailed hospital
survey conducted from 1990-1996, P. aeruginosa was the second most prevalent cause of
nosocomial pneumonia (17% of isolated microbes), the third most common cause of
urinary tract infections (11%), the fifth most common cause of surgical site infections (8
%), and the seventh most frequently isolated bloodstream pathogen (3%) (Centers for
Disease Control and Prevention, 2004). P. aeruginosa was also fifth overall in bacterial
species responsible for nosocomial infections (9%) (Centers for Disease Control and
Prevention, 2004). In the past decade, P. aeruginosa has only increased in prevalence and
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antibiotic resistance, making this organism a definite threat for susceptible patients
(Aloush et al., 2006; Edwards et al., 2007).
As an opportunistic pathogen, P. aeruginosa has the ability to colonize a number
of diverse infection sites when the host immune system is compromised (Figure 1.10).
This can occur in patients with a serious underlying condition such as cancer (Krcmery et
al., 2006), AIDS (Meynard et al., 1999), or major burn wounds (Regules et al., 2007), or
those with immune suppression from recent surgery or organ transplant (Botha et al.,
2006; Defez et al., 2004; Ullah et al.). Neonates are also very susceptible to P.
aeruginosa infection due to their underdeveloped immune system (Foca, 2002).

Figure 1.10 Various sites of P. aeruginosa infection
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P. aeruginosa can enter the body through any orifice; and minor infections, if left
unchecked, can progress into severe, life-threatening conditions. In the ophthalmological
system for instance, P. aeruginosa can colonize and infect the cornea, aqueous and
vitreous humors, or surrounding structures after cataract or corrective surgery (Kehdi et
al., 2005; Maccheron et al., 2004; Miller, 2000). Recently P. aeruginosa has been
associated with an increasing number of cases of contact lens-associated kerititis
(Robertson et al., 2007). Infections can progress quickly from minor conjunctivitis or
kerititis to scleral lesions and corneal ulcers due to cell lysis by P. aeruginosa
extracellular enzymes (Eifrig et al., 2003; Reedy & Wood, 2000).
P. aeruginosa also colonizes the auditory canal, and infection can progress from
minor otitis externa to inner ear complications (otitis media) (Clark et al., 1997; Roland,
2002). Without proper treatment secondary infections of the nearby bones (mastoiditis) or
neurological structures can occur (Butbul-Aviel et al., 2003; Penido et al., 2005).
Disruption of the gastrointestinal system often occurs in pediatric patients or those
with neutropenia or related blood disorders (Tsai et al., 1996). Colonization of the
digestive tract can range from diarrhea to severe rectal lesions and necrotizing
enterocolitis in these patients (Rowe et al., 1994).
Urinary tract infections (UTIs) are common in a hospital setting due to frequent
catheterization and the presence of drug resistant bacteria (Nicolle, 2002). If left
unchecked, these infections can lead to severe kidney disorders and renal failure.
Proximal bone infections such as osteomylitis of the pelvis and lumbosacral vertebrae can
occur as a secondary complication to UTIs (Sapico & Montgomerie, 1990).
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P. aeruginosa infection can also occur following an abrasion or break in the skin,
due to injury, surgery, or catheterization. Dermatological conditions range from minor
events such as hot-tub dermatitis or folliculitis (Yu et al., 2007) to life threatening cases
of necrotizing fascitis or cellulitis (Bodey et al., 1983; Tsekouras et al., 1998; Wortman,
1993). Infections with deep tissue damage especially in burn victims can spread to the
bloodstream causing bacteremia and septicemia (Bodey et al., 1983). Bloodborne P.
aeruginosa can travel to the heart in these cases causing endo- and pericarditis (Regules
et al., 2007).
Complications in the pulmonary system can begin as sinusitis (Danielides et al.,
2002; Koltai et al., 1985; Rombaux et al., 1997) or an upper respiratory tract infection
and lead to chronic bronchitis, pneumonia, or pulmonary lesions (Boyer et al., 2005;
Garau & Gomez, 2003; Hausermann & Gartmann, 1973; Zwillich & Ellis, 1974).
Infections of the sinuses can also lead to meningitis and cerebral lesions due to the close
proximity to the brain (Glickstein et al., 2006; Weisfelt et al., 2007; Widerman, 1953)

1.5.3 Pseudomonas aeruginosa and cystic fibrosis
The most significant complications of the pulmonary system occur among
patients with cystic fibrosis (CF), diffuse panbronchiolitis (DPB), and chronic obstructive
pulmonary disease (COPD). These patients with reduced lung function are especially
prone to chronic P. aeruginosa infection.
Cystic fibrosis is a terminal inherited disease among Caucasians, affecting 1 in
2500 live births in the United States (Registry, 2005). The gene responsible for CF,
encodes the cystic fibrosis transmembrane conductance regulator (CFTR), a protein of
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approximately 1480 amino acids (Sheppard & Welsh, 1999). Mutations in the CFTR
result in decreased function of cyclic-AMP-activated chloride channels in secretory
epithelial cells (Marcet & Boeynaems, 2006). Decreased fluid production in the lung
causes the dehydration of epithelial surfaces and oversecretion of mucus (Frizzell, 1999).
Reduced aeration and lung clearance due to thick mucosa results in increased
susceptibility to bronchopulmonary infection with P. aeruginosa among other organisms.
A switch to a mucoid phenotype presents even more problems for the CF patient
(Henry et al., 1993; Pritt et al., 2007). Nonmucoid P. aeruginosa strains in the early
stages of infection do little harm to CF lungs, and can usually be eradicated by early
aggressive antibiotic therapy (Hoiby, 1993). However, the subsequent appearance of
mucoid strains correlates with the formation of a bacterial biofilm, the development of
anti-P. aeruginosa antibodies, inflammation, and a poor prognosis for the patient (Henry
et al., 1993; Koch, 1993; Pederson, 1992; Stapper et al., 2004). Antibiotic treatment is
switched to a rotation of various antibacterial agents but ultimately fails due to decreased
lung function via bacterial consumption.

1.5.4 Current treatment protocols
Current treatment protocols can vary greatly since a patient may be infected with
one or more drug resistant strains of P. aeruginosa. Therapeutic strategies to treat
infection include administration of a single antibiotic or a combination of two or three
anti-pseudomonal agents (Banerjee & Stableforth, 2000; Jain & Singh, 2007).
Monotherapy has generally included treatment with β-lactam antibiotics such as
penicillins, cephalosporins, or newer broad-spectrum β-lactams such as imipenem and
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meropenem (Banerjee & Stableforth, 2000; Flanders et al., 2006). These antibiotics act
by interfering with the organization of peptidoglycan into bacterial cell walls (Bycroft &
Shute, 1985) (Figure 1.11). Unfortunately, P. aeruginosa has evolved an efficient way of
inactivating these drugs (discussed in the following section) which led to the
development of a number of strategic combination therapies.

Figure 1.11 Common anti-pseudomonal antibiotics and mechanisms of action.
Combinations of these drugs are often necessary for efficacy against resistant strains of P.
aeruginosa. (Image Source: Kalai Mathee)

Anti-pseudomonal cocktails include combinations of a β-lactam such as
ticarcillin, aztreonam or ceftazidime plus a β-lactamase inhibitor such as sulbactam, and
an aminoglycoside antibiotic such as tobramycin or amikacin (Banerjee & Stableforth,
2000; Flanders et al., 2006; Ostendorf et al., 2006). Aminoglycosides interfere with
protein synthesis by binding to the ribosomal subunits of the bacterial cell (Hancock,
1981; Omri et al., 1995). Combinations of ceftazidime and a fluoroquinolone such as

28

ciprofloxacin are also effective. The quinolones exhibit their bactericidal action by
blocking DNA replication through gyrase inhibition (Hooper, 1999).
Alternative combinations include pairing ciprofloxacin with an animoglycoside or
with the broad-spectrum antibiotic fosfomycin, which prevents proper cell wall formation
by inhibiting production of N-acetylmuramic acid (Flanders et al., 2006).
Although there is some success in eradicating P. aeruginosa with these treatments
many CF patients need ongoing treatment and toxicity can develop with continual use
(Banerjee & Stableforth, 2000; Registry, 2005). In addition, there is an escalating trend
of antibiotic resistance that will soon render these therapeutics ineffective.

1.5.5 Antibiotic resistance in Pseudomonas aeruginosa
According to 2004 data provided by the Centers for Disease Control, antibiotic
resistant P. aeruginosa infections are increasing (Centers for Disease Control and
Prevention, 2004). In 2004, 21.1% of the nosocomial infections were resistant to
imipenem, an increase of 15% over the previous five years (1998-2002). Similarly,
29.5% of hospital-acquired P. aeruginosa infections were resistant to quinolones and
31.9% were resistant to third generation cephalosporins; increases of 9% and 20% over
the previous five years respectively (Centers for Disease Control and Prevention, 2004).
A hospital setting is ideal for the promotion of antibiotic resistance, either through
overuse and subsequent mutation or via gene transfer (Gregory et al., 2008; Hancock &
Speert, 2000) (Figure 1.12). In addition to the more recently acquired resistance
mechanisms P. aeruginosa also has several factors that are considered intrinsic. Current
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pathogenic strains of P. aeruginosa possess inventive mechanisms which contribute to
reduced antibiotics susceptibility including:

A. Biofilm formation
B. Restricted surface accessibility
C. Exclusion via efflux pumps
D. Enzymatic inactivation of antibiotics
E. Alteration of target proteins

Figure 1.12 “Gene transfer”. Cartoon by Nick D Kim. Used with permission.
(http://www.nearingzero.net)
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1.5.5.1 Biofilm formation
"The rule of thumb is that 1,500 times more of an antimicrobial agent is needed to kill a
biofilm than a planktonic bacteria." - William Costerton.

Although the planktonic mode of bacterial growth is most often studied, the
majority of bacteria exist in nature as members of a surface-adherent, matrix-enclosed
biofilm (Costerton et al., 1995) (Figure 1.13). P. aeruginosa is no exception to this rule,
and often switches to a mucoid phenotype during infection (Mathee et al., 1999; Pritt et
al., 2007; Stapper et al., 2004). Owing to the secretion of an exopolysaccharide, biofilm
cells form a slime layer in which they are irreversibly bound to a substratum and to each
other (Donlan & Costerton, 2002). This protected formation results in altered growth
rates and transcription patterns, and more importantly, an increased environmental
resistance from that of their planktonic counterparts (Donlan & Costerton, 2002).
Antimicrobial agents are prevented from reaching the innermost cells of a biofilm and are
therefore unable to fully eradicate the infection (Hoyle & Costerton, 1991).
In addition, the alginate layer of mucoid P. aeruginosa prevents optimal host
immune function by masking antibody opsonization and inhibiting clearance (Jensen,
1993; Jensen, 1990; Pier et al., 1995). The latter is accomplished by promoting
irreversible adherence of the bacteria to lung epithelial cells.
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Figure 1.13 Biofilm formation. Polysaccharides secreted by P. aeruginosa help to adhere
cells to a surface and to each other resulting in mushroom like structures, clusters, void
spaces, water channels, and streamers. Peg Dirckx, Center for Biofilm Engineering. Used
with permission. (http://www.erc.montana.edu)

1.5.5.2 Restricted surface accessibility
If an antibiotic does manage to penetrate the structural protection of the biofilm
layer, P. aeruginosa has a second line of defense – a rather impermeable outer
membrane. For an antibiotic to be effective, it must be able to reach the periplasm or the
intercellular space of the bacterium. Outer membrane permeability is associated with a
number of channel-like proteins, or porins, which act as gate-keepers for molecules
wishing to gain entry into the cell. The outer membrane of P. aeruginosa is estimated to
be up to 100 times less permeable than that of E. coli (Yoshimura & Nikaido, 1982). This
is due, in part, to the difference in size and structure of the porins. The outer membrane
proteins (Oprs) found in P. aeruginosa had much lower molecular weights than their E.
coli counterparts (Mizuno & Kageyama, 1978; Yoshihara & Nakae, 1989) and existed as
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monomers (Yoshimura et al., 1983), whereas the E. coli porins had a larger, trimeric
quaternary structure. Modulation of permeability, and thus antibiotic susceptibility in P.
aeruginosa, has been shown to occur with changes in expression or mutations of the Opr
genes (Yoneyama et al., 1991; Yoneyama et al., 1995; Young et al., 1992).

1.5.5.3 Exclusion via efflux pumps
Once an antibiotic gains entry into the cell, P. aeruginosa has a number of threecomponent efflux mechanisms in place to remove it before it causes damage. The
tripartite efflux system combines an outer membrane protein described in the previous
section (e.g. OprM), an energy-dependant pump located in the cytoplasmic membrane
(MexB), and a protein to connect the two (MexA)(Nehme et al., 2004). This system
creates a channel which extends from the inner membrane all the way to the outside of
the cell and uses proton motive force to extrude unwanted chemicals (Figure 1.14). P.
aeruginosa expresses a number of these multidrug efflux (Mex) systems, including
MexAB-OprM, MexXY-OprM, MexCD-OprJ, MexEF-OprN and MexJK-OprM
(Chuanchuen et al., 2002; Hocquet et al., 2003; Llanes et al., 2004; Maseda et al., 2000;
Masuda et al., 2000; Poole, 2001). These systems vary slightly in their preferred
substrates, however their combined effect removes most known classes of antibiotics
including β-lactams (and β-lactamase inhibitors), macrolides, aminoglycosides,
fluoroquinolones, tetracyclines, and chloramphenicol (Poole & Srikumar, 2001). Hyperexpression of these efflux genes by mutational events or acquired genetic material has
been shown to result in substantially increased antibiotic resistance (Beinlich et al., 2001;
Llanes et al., 2004).
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Figure 1.14 MexAB-OprM efflux pump of P. aeruginosa. This system extrudes drugs
using proton motive force (modified from (Schweizer, 2003)). OM = outer membrane,
CM = cytoplasmic membrane.

1.5.5.4 Enzymatic inactivation of antibiotics
P. aeruginosa is able to inactivate many β-lactam antibiotics by enzymatic
cleaving of the β-lactam ring (Figure 1.15) (Abraham & Chain, 1940). Older antibiotics
in the β-lactam class such as ampicillin and penicillin have almost no effect on current
strains of P. aeruginosa. Newer β-lactams are still used to treat infections with this
organism, however, resistance is on the rise and soon these too will become obsolete.
β-lactamases are separated into four distinct classes based on structure, function,
and substrate specificity (Abraham & Chain, 1940). P. aeruginosa can carry one or more
β-lactamases from any of the Ambler classes A-D (Ambler, 1980).
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Figure 1.15 Core structure of Penicillin, typical of β-lactam antibiotics. Red line
indicates site of cleavage by β-lactamases. (http://en.wikipedia.org/wiki/Image:Penicillincore.png)

Ambler class A β-lactamases, or penicillinases, were the first identified and most
variable class of these enzymes (Matagne et al., 1990). They act via a serine hydrolasedriven mechanism, and generally have activity against the older penicillin derivatives.
The most notable enzymes in this class are the chromsomally mediated TEM (isolated
from patient Temoniera) and SHV (sulphydryl variable) families in P. aeruginosa
(Mugnier et al., 1996; Naas et al., 1999; Poirel et al., 1999) and the plasmid-encoded
CARB, which confers carbenicillin resistance (Boissinot & Levesque, 1990; Lachapelle
et al., 1991). Class A β-lactamases generally lack activity against cephalosporins and
carbepenems, however, a number of extended spectrum β-lactamases (ESBLs) are
emerging throughout Europe and Asia (Weldhagen et al., 2003). These ESBLs have
increased activity against several broad-spectrum antibiotics, severely limiting treatment
options (Weldhagen et al., 2003).
Ambler class B enzymes are metallo-β-lactamases which require zinc for
activation (Ambler, 1980; Bush et al., 1995). The first of these (IMP-1) was isolated from
a Japanese strain of P. aeruginosa (Watanabe et al., 1991). IMP appears to be widely
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distributed throughout Gram negative bacteria and confers resistance not only to
imipanem, but to advanced cephalosporins, penicillins, and several β-lactamase inhibitors
as well (Watanabe et al., 1991). In addition, IMP genes are encoded on a class 1 integron
on a plasmid conferring resistance to additional classes of antibiotics. The ease of intraand interspecies transfer of plasmids of this type has resulted in multi-drug resistant
(MDR) strains of P. aeruginosa and other pathogenic organisms (Walsh et al., 2005). A
second, class B enzyme with a strong resistance to carbapenem (VIM) is becoming
increasingly present as well (Lauretti et al., 1999; Tsakris et al., 2000).
Class C β-lactamases, or cephalosporinases, like Class A enzymes use a serinehydrolase mechanism to cleave the β-lactam ring of invading drugs (Sanders, 1987).
These chromosomally encoded enzymes are highly conserved (Galleni et al., 1988), and
the most recognized enzyme, ampC from P. aeruginosa, has been cloned and sequenced
(Lodge et al., 1990). Most class C β-lactamases including ampC are inducible in P.
aeruginosa. They are produced at a basal level until the cell is challenged with a β-lactam
antibiotic, at which point P. aeruginosa upregulates lactamase production, reduces its
outer membrane permeability, and creates a resistant nonhydrolytic barrier (Sanders &
Sanders, 1985). This results in theraputic failure for not only the β-lactams but for other
classes of drugs as well.
The Class D group of β-lactamases are structurally similar to Class A enzymes,
but are functionally described as oxacillinases for their ablilty to degrade isoxazolyl βlactams such as methicillin and oxacillin (Naas & Nordmann, 1999). Oxacillinases (OXA
family) are ubiquitous thoughout Gram negative bacteria and are generally plasmid- or
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transposon-encoded. However, a chomosomally encoded oxacillinase, PoxB, has also
been characterized for P. aeruginosa (Girlich et al., 2004; Kong et al., 2005). As with
Class A, treatment-compromising Class D ESBLs are becoming more prevalent in P.
aeruginosa infections (Poirel, 2002).

1.5.5.5 Alteration of target proteins
P. aeruginosa has yet another method for dealing with β-lactam antibiotics – the
expression of modified penicillin binding proteins (PBPs). Normal PBPs are membranebound or cytoplasmic proteins, that play a role in peptidoglycan and cell wall synthesis
(Georgopapadakou & Liu, 1980; Noguchi et al., 1979). Penicillin and related β-lactams
need to bind these PBP targets to exhibit their antibiotic effect. Mutations in PBPs
decrease binding affinity to the target and subsequently antibiotic susceptibility (Curtis et
al., 1981; Noguchi et al., 1980). P. aeruginosa synthesizes at least nine divergent PBPs
(Georgopapadakou & Liu, 1980; Stover et al., 2000) which have a reduced binding
affinity to penicillin when compared to those in E. coli (Curtis et al., 1979). In addition, a
number of mutations have been found in clinically-isolated strains with increased
resistance to imipenem (Bellido et al., 1990), titarcillin and piperacillin (Godfrey et al.,
1981), and cefsulodin (Gotoh et al., 1990). Still further accumulation of mutations in a
hospital setting will add new complications to antibiotic treatment.

1.5.6 Pseudomonas aeruginosa QS specifics
With the difficulty in treating recalcitrant infections in the CF patient and the
growing resistance to antibiotics, new therapeutic modalities are becoming increasingly
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necessary. Targeting the QS system of P. aeruginosa, one of the major complicating
pathogens in the CF lung, is a novel plan of attack. This system is a key regulator of
pathogenicity in P. aeruginosa and other medically relevant bacteria, thus inhibition of
QS may cause attenuation of virulence and protect against infection (Hentzer & Givskov,
2003; Juhas et al., 2005; Smith & Iglewski, 2003a).
The main QS system of P. aeruginosa is based on the luxI-luxR paradigm
described previously. This intricate communication system is mirrored in many gramnegative pathogenic bacteria, where it coordinates regulation of virulence, including
motility, biofilm formation, and toxin production (for a review see (De Kievit &
Iglewski, 2000; Fuqua & Greenberg, 1998; Schauder & Bassler, 2001)). P. aeruginosa
elaborates two main sets of QS systems: lasI-lasR and rhlI-rhlR (Schuster & Greenberg,
2006). The LuxI homologues, LasI and RhlI are synthetases that manufacture the
autoinducer signaling molecules N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL)
and N-butanoyl-L-homoserine lactone (BHL), respectively (Pearson et al., 1994; Pearson
et al., 1995). These signaling molecules diffuse out into the environment and, upon
reaching a putative threshold concentration, activate receptors lasR and rhlR (Pesci et al.,
1997). These receptors, in turn, coordinate regulation of pathogenicity through
transcriptional activation of a number of virulence factors (Brint & Ohman, 1995; Latifi
et al., 1995; Winson et al., 1995).
A third signal, PQS (Pseudomonas Quinolone Signal), also plays an integral role
in the QS system and is implicated in the production of N-(3-oxohexanoyl)-L-homoserine
lactone (OHHL) (McKnight et al., 2000; Pesci et al., 1999). This secondary metabolite of
P. aeruginosa is incorporated into the QS hierarchy in times of cell stress (McKnight et
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al., 2000), and interference with this signal has been shown inhibit virulence factor
expression (Calfee et al., 2001) It has also been suggested that a fourth system exists
regulated by cyclic dipeptides (DKPs) (Holden, 1999). However, due to time constraints,
this study focuses on the well-defined las and rhl systems.
Although the redundant and auto-regulatory nature of the QS system is quite
complex (Van Delden & Iglewski, 1998), the basic view of the P. aeruginosa QS
hierarchy suggests that las controls rhl with virulence proteins at the bottom of the ladder
(Schuster & Greenberg, 2006) (Figure 1.16). The virulence factors LasA (staphylolytic
protease) and LasB (elastase) are thought to be under control of the lasI/R system
(Gambello, 1991; Storey et al., 1998), however rhlI/R also controls activity to a lesser
extent (Brint & Ohman, 1995; Pearson et al., 1997). Pyoverdin is believed to be under
rhlI/R control (Brint & Ohman, 1995; Whiteley, 1999), whereas biofilm production is
only partially under QS control (Davies et al., 1998). The las-rhl system also falls under
the umbrella of a number of “global” regulators such as Vfr (a homologue of E. coli
cAMP receptor protein, CRP) (Albus et al., 1997) or GacA (a sRNA binding protein)
(Reimmann et al., 1997). Control from these genes also affects downstream virulence.
Thus, to inhibit pathogenicity, a therapeutic compound could exhibit an effect
directly on the las/rhl system, one of the global regulators, or the PQS or DKP pathways.
The only known anti-QS compounds, the halogenated furanones, inhibit P. aeruginosa
both in vitro and in a murine model (Hentzer et al., 2002; Hentzer et al., 2003; Wu et al.,
2004). These compounds function by displacing the signaling molecule from its receptor,
thus accelerating receptor turnover (Manefield et al., 1999; Manefield et al., 2002). They
also have an influence on siderophore biosynthesis (Ren et al., 2005).
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Figure 1.16 The main QS system in P. aeruginosa (modified from (Schuster &
Greenberg, 2006)). LasI and RhlI synthetases manufacture the autoinducer signaling
molecules OdDHL and BHL respectively. These signaling molecules diffuse out into the
environment and, upon reaching a threshold concentration, activate receptors lasR and
rhlR. These receptors each control a regulon of genes including virulence factors.

Recently, a few plants have shown anti-QS activity against P. aeruginosa
(Rasmussen et al., 2005), however the responsible compounds and mechanism of action
are yet unknown. The potential for finding anti-pseudomonal and anti-QS activity in
medicinal plants is considerable, relatively unexplored, and will be the focus of this
study.
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1.6 Infection model: Caenorhabditis elegans
In vivo activity is often quite different than in vitro effect, and thus an animal
model is a necessary step closer to therapeutic relevance. Significant to this study, are the
number of P. aeruginosa virulence factors relevant in the killing of both nematode and
mammalian tissues (Rahme et al., 1995; Tan et al., 1999a).
The nematode Caenorhabditis elegans (Figure 1.17) was developed as an animal
model in the mid 1960s by Sidney Brenner (Brenner, 1974). With its small chromosome
number and only 556 cells at hatching, C. elegans was posed as an alternative to the
larger, more complex Drosophila model.

The 1 mm long roundworm is a self-

reproducing hermaphrodite with a life-cycle of approximately 3.5 days (Brenner, 1974).
It lends itself easily to culture and propagation on Escherichia coli strain OP50, and
hundreds of progeny can be generated rapidly in petri dishes.

Figure 1.17 Caenorhabditis elegans. (Modified from http://www.wormatlas.org)

Although originally chosen for genetic and neurological study, C. elegans was
later established as a practical model for studying bacterial virulence (Darby et al., 1999;
Tan & Ausubel, 2000). In addition to its preferred meal of E. coli, this voracious
nematode will consume almost any bacteria that can fit down its pharynx, resulting in
intestinal infection and worm death with a number of pathogenic species.
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Three major models of infection have been developed for exploring the effect of
P. aeruginosa on C. elegans; “fast-killing”, “slow-killing”, and “paralytic” models. Fastkilling of C. elegans occurs within hours of incubation with P. aeruginosa strain PA14 on
rich media (Mahajan-Miklos et al., 1999). The high-nutrient media allows maximum
production of bacterial virulence factors such as phenazines and other toxins, which are
absorbed through the hypoderm, or skin, of C. elegans. Slow-killing occurs over a period
of days via ingestion of bacteria and subsequent infection, when the nematode is
incubated with strain PA14 on minimal media (Tan et al., 1999a; Tan et al., 1999b).
Paralytic killing is seen with the related P. aeruginosa strain PAO1, which causes death
within hours through cyanide poisoning and neuromuscular paralysis (Gallagher &
Manoil, 2001).
Relevant to this study, is that P. aeruginosa-mediated killing of C. elegans in all
of these cases is dependent on the QS system (Darby et al., 1999; Mahajan-Miklos et al.,
1999; Tan et al., 1999b). Since virulence has been shown both in vitro and in a nematode
model to be mediated by the bacterial QS system, the addition of plant compounds that
attenuate P. aeruginosa QS, should therefore decrease virulence factor production and
subsequent death of C. elegans.
An additional advantage in using a live animal model for screening of potential
anti-infective compounds is that both efficacy and host toxicity of a plant extract can be
tested concurrently. This approach can be expanded to the screening of natural product
libraries to search for compounds that cause a marked decrease in P. aeruginosa killing
of C. elegans, without affecting worm fitness on E. coli.
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1.7 Main hypotheses and aims of this project
Hypothesis: Anti-QS compounds may contribute to the anti-infective properties
of some traditionally used plants, and that these compounds can affect virulence and
biofilm formation in human pathogenic organisms such as P. aeruginosa. Furthermore,
extracts from plants with anti-QS properties should prevent infection and death in a live
animal model system.

Specifically this research will explore the following aims:
I.

Investigate the presence of anti-QS activity in south Florida medicinal plants.

II.

Determine if these plants can affect the QS system and virulence factors of
P. aeruginosa.

III.

Test the ability of anti-QS plants to prevent infection in the model organism
C. elegans.

IV.

Purify and characterize the active compounds in these plant species.

The following research introduces not only a new mode of action and possible
validation for traditional plant use, but also a new therapeutic direction for CF and other
conditions complicated by bacterial infection.
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Chapter 2

“Anti-quorum sensing activity of medicinal plants in southern Florida”

As published in the Journal for Ethnopharmacology
January 2006
Volume 105, Pages 427-435
Copyright © Elsevier

Allison L. Adonizio, Kelsey Downum, Bradley C. Bennett, Kalai Mathee
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2.1 Abstract
Bacterial intercellular communication, or quorum sensing (QS), controls the
pathogenesis of many medically important organisms. Anti-QS compounds are known to
exist in marine algae and have the ability to attenuate bacterial pathogenicity. We
hypothesized that terrestrial plants traditionally used as medicines may also produce antiQS compounds. To test this hypothesis, 50 medicinal plants from southern Florida were
screened for anti-QS activity using two biomonitor strains, Chromobacterium violaceum
and Agrobacterium tumefaciens. Of these plants, six showed QS inhibition: Conocarpus
erectus L. (Combretaceae), Chamaecyce hypericifolia (L.) Millsp. (Euphorbiaceae),
Callistemon viminalis (Sol.ex Gaertn.) G. Don (Myrtaceae), Bucida burceras L.
(Combretaceae), Tetrazygia bicolor (Mill.) Cogn. (Melastomataceae), and Quercus
virginiana Mill. (Fagaceae). This study introduces not only a new mode of action and
possible validation for traditional plant use, but also a potentially new therapeutic
direction for the treatment of bacterial infections.

Keywords: Medicinal plants; Antimicrobial activity; Quorum sensing; Anti-quorum
sensing; Southern Florida, Anti-infective potential

Abbreviations: QS, Quorum Sensing; AHL, Acyl-Homoserine Lactone; X-gal, 5-bromo4-chloro-3-indoyl-β-D-galactopyranoside; WT, Wild Type
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2.2 Introduction
Whether for traditional use-validation or drug discovery purposes, previous
studies have focused on the antibacterial potential of medicinal plants (e.g.: (Cowan,
1999; Wallace, 2004)). Investigations were restricted to whether or not a plant could kill
or inhibit the growth of bacteria. However, this is only one facet of a plant’s antiinfective potential. The antipathogenic properties of plants have received much less
attention, but may be just as important in combating disease as their antibacterial
counterparts.

The interruption of quorum sensing (QS), or bacterial cell-to-cell

communication, is one example of an antipathogenic effect. Since a large number of
systems affecting pathogenicity are controlled by QS, interrupting this communication
system can render pathogenic bacteria non-virulent (Zhang & Dong, 2004).
Quorum sensing (QS) is a population-dependent phenomenon first characterized
in the 1970s in luminescent marine species of Vibrio (Hastings & Greenberg, 1999;
Nealson et al., 1970). QS systems are ubiquitous in bacteria, and have since been found
to regulate diverse cellular functions including luminescence, biofilm formation,
antibiotic production, virulence factor expression, pigment production, plant-microbe
interactions, and motility (Fuqua & Greenberg, 2002; Whitehead et al., 2001a). In QS,
small signaling molecules called autoinducers mediate the ability to sense the size of a
bacterial population (Eberhard et al., 1981). Autoinducers are constantly produced and
received at a basal level by bacterial cells. With high population density, there is a
surplus of such molecules in the environment (Hastings & Greenberg, 1999). These
molecules then interact with a transcriptional regulator to activate the expression of genes
involved in light production in luminescent Vibrio species (Fuqua et al., 1994). In other
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bacteria, these chemical signals are important for the establishment of infection and can
serve as a switch to a pathogenic state (De Kievit & Iglewski, 2000; Sircili et al., 2004;
Wu et al., 2001).
Several signaling molecules have been identified (Dong & Zhang, 2005); the bestcharacterized being the acyl-homoserine lactones (AHLs) in Gram-negative bacteria
(Eberhard et al., 1981). The AHLs are highly conserved, having the same homoserine
lactone moiety but different acyl side chains and substitution (carbonyl or hydroxyl) at
the C3 carbon (Fuqua & Greenberg, 2002). AHL-mediated quorum sensing systems have
been characterized in bacteria associated with human disease, e.g.: Pseudomonas
aeruginosa (Smith & Iglewski, 2003b), Yersinia pseudotuberculosis (Atkinson et al.,
1999), Clostridium difficile (Carter et al., 2005), Burkholderia cepacia (Lutter et al.,
2001) and Escherichia coli (Surette & Bassler, 1998); as well as plant associated bacteria
e.g.: Rhizobium leguminosarum (Rodelas et al., 1999), Ralstonia solanacearum, and
Erwinia carotovora (Von Bodman et al., 2003). The discovery of the QS system and its
critical role in bacterial virulence and survival has revealed a new target - a novel way to
attack and attenuate bacterial pathogenicity.
There are a number of ways to interrupt the QS system. Thus anti-quorum sensing
(anti-QS) compounds can be of great interest in the treatment of bacterial infections (Fast,
2003; Rice et al., 2005). A number of quorum-quenching enzymes that hydrolyze AHLs
have been identified in bacteria (Dong & Zhang, 2005). To date, the only known anti-QS
compounds of non-bacterial origin are halogenated furanones from the red alga Delisea
pulchra (Manefield et al., 1999). Anti-QS activity has also been shown in a number of
southern Florida seaweeds (Cumberbatch, 2002) and a few terrestrial plants (Gao et al.,
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2003; Teplitski et al., 2000). However, so far, only a handful of higher plants have been
studied, and nothing has been published with regard to anti-QS activity in medicinal
plants.
The plant kingdom has long been a source of medicines and is estimated to
provide over half of today's pharmaceuticals (Balandrin et al., 1993). The emergence of
antibiotic resistance begs the need for novel therapeutics. It has been suggested that
targeting the QS system, instead of killing bacteria, may provide a solution to antibiotic
resistance (Hentzer & Givskov, 2003b). With the promise of anti-QS compounds, one
should be compelled to search for these agents by the most efficient method possible.
There have been many ethnobotanically-directed searches for agents to treat infection,
demonstrating not only the need for these drugs, but also the large number of plants
utilized for bacterial conditions (e.g.: (Camporese et al., 2003; Cowan, 1999; Gnanamani
et al., 2003; Hernandez et al., 2003)). Although this antibacterial effect is important, it is
not the only source of a plant's medicinal properties. Shifting the focus from the strictly
antibacterial to anti-QS properties of plants may reveal new anti-infective compounds
and provide use validation for traditional medicinals.
Using two different biomonitor strains selected for their QS genetics, we were
able to screen southern Florida plants for anti-QS activity. We have found anti-QS
activity in six out of 50 plants, and in most cases this activity is retained upon extraction
into common solvents.
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2.3 Materials and methods
2.3.1 Collection of plant material and extract preparation
Fifty plant species (Table 2.1) were collected in the Florida International
University Environmental Preserve and Miami-Dade County, FL from February-May
2004. Plant selection was based on availability and ethnobotanical use categories relating
to infection (Burkhill, 1985; Duke, 1972; Duke, 1985; Duke, 2000; Liogier, 1990;
Morton, 1981).

These categories include plants used to treat wounds, burns, and

dermatitis; conditions that favor microbial colonization.

Plants were collected and

processed in triplicate. All plants were identified by the authors and vouchers were
deposited in the herbarium at Fairchild Tropical Botanic Garden (FTG), Miami, FL.
As a preliminary screen, unwashed leaves from 10 species were compared with
leaves washed in ethanol to determine the effect of surface microbes and epiphylls.
Plants were then processed and tested in four stages using two biomonitor strains
(described in the following section). Testing of fresh material composed the primary
screen, as it was faster and ethnomedicinally analogous to poultices. Plants that showed
anti-QS activity as fresh material were tested in dried form. Those that still retained
activity after drying were tested as water and ethanol extractions.

Screening was

performed in this manner, rather than testing extracts only, since certain chemicals may
have been lost or altered during processing.
For ethanolic extracts, plants were separated into component parts and dried in a
plant drier for approximately for 24 h. Dried plant matter was ground and added to 95 %
ethanol (100 g dry wt/ L), and allowed to stand for 24 hours before vacuum filtration with
filter paper (Whatman, 1001-270, Florham Park, NJ) to remove particulate matter. An
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aliquot was removed to test for anti-QS activity at the 100 g/L concentration. The
remainder was evaporated to dryness using a rotoevaporator (Buechi R-114, Uster,
Switzerland) and stored at –20 °C.
In addition, water extracts were prepared for the six species that proved active as
fresh material. Plants were processed as above, dried material was added to sterile water
at 100 g dry wt/L, and boiled for 5 min. An aliquot was removed for testing and the
remainder of the decoction was frozen at –80 °C for 24 hours and then freeze-dried using
a lyophilizer. The lyophilized extracts remained at –20 °C to be reconstituted in sterile
water as needed. Filtration of the water extracts using a 0.2 µm (pore size) filter into
autoclaved vials ensured sterility of the samples. Extracts were tested for microbial
contamination at every step of processing, by streaking to LB agar plates, to minimize the
potential for introduction of exogenous anti-QS compounds.

Table 2.1 Southern Florida medicinal plants tested for anti-QS activity.
Collection
#

a

Species

Family

Common
name

Part tested

Medicinal use

ALA49

Asclepias
curassavica L.

Apocynaceae

scarlet
milkweed

flowers, leaves

emetic,
vermifuge, skin
disease,
leucorrhea

ALA3

Bauhinia
variegata L.

Fabaceae

orchid tree

flowers, leaves

other spp. asthma,
venereal disease,
influenza

ALA4

Bidens alba var.
radiata (Sch. Bip.)
R.E. Ballard

Asteraceae

beggarticks,
romerillo

aerial

Bidens pilosa L.
for dysentery,
catarrh,
vermifuge,
wounds, sores

ALA30

Bougainvillea
spectabilis Willd.

Nyctaginaceae

bougainvillea flowers, leaves
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other spp.
wounds, cough

ALA31

Bucida buceras L. Combretaceae

black olive

ALA21

Bursera simaruba
(L.) Sarg.

Burseraceae

gumbo-limbo bark

fever, venereal
disease, diarrhea,
skin disease, sore
throat, colds,
asthma

ALA20

Callistemon
viminalis (Sol. ex
Gaertn.) G. Don

Myrtaceae

bottlebrush

flowers/bracts,
leaves

Melaleuca spp.
antiseptic, acne,
bronchitis, cough,
diarrhea, skin
disorders

ALA5

Casuarina
equisetifolia L.

Casuarinaceae

Australian
pine

leaves

skin disorders,
diarrhea,
dysentery, sore
throat

ALA6

Catharanthus
roseus (L.) G.
Don

Apocynaceae

Madagascar
periwinkle

flower, leaves

asthma,
flatulence,
opthalmia,
tuberculosis,
vermifuge,
mouthwash

ALA10

Chamaesyce
hypericifolia (L.)
Millsp.

Euphorbiaceae

graceful
sandmat

aerial

abrasions,
diarrhea,
dysentery,
leucorrhea,
opthalmia,
respiratory
problems

ALA12

Chrysobalanus
icaco L.

Chrysobalanaceae cocoplum

leaves

dysentery,
leucorrhea,
diarrhea

ALA13

Coccoloba uvifera Polygonaceae
(L.) L.

seagrape

leaves

dysentery,
diarrhea, asthma,
wounds, skin
disease

ALA14

Conocarpus
erectus L.

Combretaceae

buttonwood

leaves

febrifuge,
respiratory
ailments, venereal
disease

ALA37

Costus
pulverulentus
C. Presl

Costaceae

costus

flowers/bracts, cough, dysentery,
leaves, rhizome venereal disease

ALA17

Crotalaria pumila
Ortega

Fabaceae

low rattlebox aerial
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leaves

gonorrhea

Crotalaria incana
L., Crotalaria
fulva Roxb. for
yellow fever, rash

ALA51

Cymbopogon
citratus (DC.)
Stapf

Poaceae

lemongrass

leaves

stomachic, fever,
colds,
tuberculosis

ALA32

Datura metel L.
“Double Purple”
c.v.

Solanaceae

angel’s
trumpet

flowers, leaves

febrifuge,
stomachache,
asthma

ALA33

Emilia fosbergii
Nicolson

Asteraceae

florida
tassleflower

whole plant

Emilia coccinea
(Sims) G. Don for
opthalmia,
asthma,
stomachache

ALA18

Erigeron
quercifolius Lam.

Asteraceae

oakleaf
fleabane

aerial

Erigeron
karvinskianus
D.C. as cold
remedy

ALA15

Ficus aurea Nutt.

Moraceae

strangler fig

leaves, latex

coughs

ALA16

Hamelia patens
Jacq.

Rubiaceae

firebush

flowers, leaves

dysentery, skin
disease, sores,
blisters, eczema,
stomachache

ALA19

Heliotropium
polyphyllum
Lehm.

Boraginaceae

pineland
heliotrope

aerial

other spp. sore
throat, asthma,
cough, bronchitis,
dysentery, eye
wash

ALA38

Hibiscus rosasinensis L.

Malvaceae

garden
rosemallow,
hibiscus

flowers

cold remedy,
influenza,
asthma,
opthalmia,
wounds

ALA34

Ixora coccinea L.

Rubiaceae

scarlet
jungleflame

flowers, leaves

bronchitis,
catarrh, diarrhea,
fever, sore

ALA7

Lantana depressa
L.

Verbenaceae

rockland
lantana

flowers, leaves

stomachic,
wound, colds,
fever, asthma,
veneral disease,
bronhitis

ALA40

Lepidium
virginicum L.

Brassicaceae

pepperweed

aerial

mouth sores, skin
disease, stomach
ailments,
vermifuge,
diarrhea,
dysentery
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ALA1

Oxalis corniculata Oxalidaceae
L.

yellow
woodsorrel

leaves

skin conditions,
antiseptic, sore
throat, stomach
problems

ALA23

Parthenocissus
quinquefolia (L.)
Planch.

Vitaceae

Virginia
creeper

aerial

antiseptic, fever,
diarrhea

ALA42

Passiflora
coccinea Aubl.

Passifloraceae

red passion
vine

flowers, leaves

fever,
conjunctivitis

ALA24

Physalis walteri
Nutt.

Solanaceae

groundcherry leaves

Physalis angulata
L. gonorrhea,
fever, Physalis
pubescens L.
stomachic

ALA43

Plantago major L. Plantaginaceae

common
plantain

leaves

wounds, boils,
dysentery,
diarrhea, colds

ALA8

Psychotria
nervosa Sw.

Rubiaceae

wild coffee

leaves

colds, stomach
problems

ALA44

Quercus
virginiana Mill.

Fagaceae

live oak

leaves

febrifuge,
diarrhea,
antiseptic

ALA11

Rhynchospora
colorata (L.) H.
Pfeiff.

Cyperaceae

starrush,
whitetop

aerial

colds, bronchitis

ALA25

Ricinus communis
L.

Euphorbiaceae

castorbean

leaves

leaf decoction
wash for sores

ALA27

Schefflera
actinophylla
(Endl.) Harms

Araliaceae

Australian
leaves
umbrella tree

wound

ALA28

Schinus
terebinthifolius
Raddi

Anacardiaceae

Brazilian
pepper

leaves

diarrhea, skin,
wound

ALA45

Senna alata (L.)
Roxb.

Fabaceae

candlestick
plant

flowers, leaves

diarrhea,
vermifuge,
venereal disease,
ringworm,
eczema, grippe,
catarrh

ALA50

Stachytarpheta
jamaicensis (L.)
Vahl

Verbenaceae

blue
porterweed,
joee

leaves

boils, vermifuge,
coughs, fever,
skin ailments,
diarrhea, venereal
disease
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a

ALA46

Swietenia
mahagoni Jacq.

Meliaceae

west Indian
mahogany

leaves

diarrhea,
febrifuge, colds,
catarrh, venereal
disease

ALA35

Tabebuia aurea
(Silva Manso)
Benth. & Hook. f.
ex S. Moore

Bignoniaceae

Caribbean
trumpettree

flowers, leaves

Tabebuia
bahamensis
(Northr.) Britton
for gonorrhea,
Tabebuia rosea
(Bertol.) A.D.C.
fever, colds

ALA2

Tetrazygia bicolor Melastomataceae
(Mill.) Cogn.

Florida
clover ash

leaves

night sweats

ALA47

Tillandsia
recurvata (L.) L.

Bromeliaceae

ballmoss

whole plant

leucorrhea

ALA9

Trema micrantha
(L.) Blume

Cannabaceae

nettletree

leaves, stem,
fruits

skin eruptions

ALA29

Vitis rotundifolia
Michx.

Vitaceae

muscadine

aerial

Vitis caribaea
D.C. for venereal
disease, skin
condition,
diarrhea

ALA65

Annona glabra L.

Annonaceae

pond apple

leaves, fruit

diarrhea, burns,
cough, dysentery

ALA66

Ficus citrifolia
Mill.

Moraceae

wild banyan
tree

leaves, latex,
fruits

wounds

ALA64

Mangifera indica
L.

Anacardiaceae

mango

leaves

cough, bronchitis,
asthma, fever,
diarrhea, sores,
skin disorders

ALA67

Solanum
americanum Mill.

Solanaceae

American
black
nightshade

leaves, fruits

stomachic,
ringworm,
eyewash,
earwash, wounds,
abscess, sores

Species nomenclature follows (Wunderlin & Hansen, 2004). Family nomenclature follows (APGII, 2003).
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2.3.2 Biomonitor organisms
Chromobacterium violaceum: In C. violaceum (ATCC 12472), production of a
purple pigment, violacein, is under QS-control (Lichstein & van de Sand, 1945; Throup
et al., 1995). This wild type strain produces and responds to the cognate autoinducer
molecules C6-AHL and C4-AHL. The second biomonitor strain, CVO26, is a mutant of
the wild type strain that is unable to produce its own AHL signal, but responds to
exogenous active signal molecules (Cha, 1998). Anti-QS compounds inhibit production
of violacein in both cases making these strains excellent for screening (McClean et al.,
2004).
Agrobacterium tumefaciens NTL4 (pZLR4):

A. tumefaciens strain NTL4

harboring plasmid pZLR4 (Luo et al., 2003) was used for the detection of both short
(C6) and long-chain (C12) AHL suppression. In this system, the reporter gene (lacZ) is
fused to a QS-dependant promoter. Activation of this promoter by exogenous AHLs
causes concomitant expression of β-galactosidase, which produces a blue color by
cleaving

the

chromophor

from

supplemented

5-bromo-4-chloro-3-indoyl-β-D-

galactopyranoside (X-gal). Anti-QS compounds inhibit the QS-dependant promoter and
subsequent lacZ expression, thus limiting X-gal hydrolysis, and the appearance of blue
color.

2.3.3 Bioassays
Fresh or dried plant material was ground using a mortar and pestle and placed
directly onto Luria Bertani (LB) plates spread with either C. violaceum (wt), CV026
supplemented with AHL, or A. tumefaciens NTL4 supplemented with AHLs and X-gal.
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Plates were incubated overnight at 30 °C, and QS inhibition was detected by a ring of
colorless, but viable, cells around the disk. Purified halogenated furanone (100 µg ) was
used as a positive control for QS inhibition, and ethanol (20 µL) as a negative control.
The ethanol was allowed to evaporate from the control and sample discs before testing to
eliminate toxicity. A third control (tetracycline or gentamycin 10 µg per disc) was
included to compare antibiotic effect with anti-QS activity.

2.3.4 Disk diffusion method
Standard disc-diffusion assays were used to detect anti-QS activity of the plant
extracts (Bauer et al., 1966). Each extract (20 µL) was loaded onto sterile disks (6 mm
diameter) placed onto prepared LB plates spread with overnight culture (100 µL) of C.
violaceum wt, CV026, or A. tumefaciens NTL4. AHL (30 µg) was added to both the
CV026 and NTL4 plates, and 50 µL of X-gal stock solution (20 mg/ml) was added to
NTL4. Plates were incubated at 30 °C overnight and QS inhibition was detected by a
ring of colorless but viable cells around the disk. Measurements were made from the
outer edge of the disks to the edge of the zones of anti-QS inhibition. Controls were as
previously described.

2.4 Results
2.4.1 Preliminary screen to determine effect of surface microbes and processing
To determine whether anti-QS compounds were actually from the plants
themselves or from epiphyllic microorganisms, ethanol-washed plant material was
compared with unwashed, placing whole or macerated leaves directly onto a prepared C.
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violaceum plate (Figure 2.1). No difference in anti-QS activity was observed in leaves
without visible contamination (Figure 2.1) and only a slight increase in activity with
leaves covered in epiphylls (data not shown). A second comparison between whole and
macerated leaves revealed anti-QS activity only in crushed leaves (Figure 2.1). A third
comparison between fresh and dried macerated leaves illustrated that in all cases tested
both states retained anti-QS effect though in some cases it was reduced (data not shown).

Figure 2.1 Preliminary screening of C. erectus for anti-QS activity using C. violaceum
biomonitor strain.

A yellowish “halo” of bacteria indicates an anti-QS effect. The

samples were (1) washed whole leaf, (2) washed macerated leaves, and (3) unwashed
macerated leaves of fresh C. erectus. As negative controls (4) washed, and (5) unwashed
leaves of Hamelia patens and (6) sterile paper disk were included.
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2.4.2 Anti-quorum sensing activities in southern Florida plants using C. violaceum
assays
Loss of purple pigment in C. violaceum is indicative of QS inhibition by the plant
products introduced (Figure 2a). Out of 50 southern Florida plants (Table 2.1) screened
for anti-QS activity, six species proved to be effective: C. erectus, Q. virginiana, T.
bicolor, B. buceras, C. viminalis and C. hypericifolia (Table 2.2). The anti-QS activity of
the six active species as fresh, dried, water-extracts, and ethanol-extracts were screened
using the C. violaceum bioassays (Figure 2.2a and Table 2.2). Control discs containing
halogenated furanone, gentamycin, and ethanol were included. As expected, a zone of
growth inhibition was observed with gentamycin, a zone of QS inhibition (halo) was seen
with the furanone, and no inhibition was apparent with ethanol (Figure 2.2a).
Strong anti-QS activity was observed in both the water and ethanol extracts of C.
erectus, C. viminalis (inflorescence), B. buceras, and T. bicolor (Figure 2a and Table 2).
For all species except T. bicolor and C. hypericifolia, the water extracts were more
effective than those in ethanol. CV026 produced smaller halos overall, and no activity
was detected with water extracts of C. viminalis and Q. virginiana leaves using this strain
(Table 2).

2.4.3 Anti-quorum sensing activities in southern Florida plants using
A. tumefaciens assays
Loss of blue color in A. tumefaciens strain NTL4 (with added AHL) is indicative
of QS inhibition by the plant products introduced as described in Materials and Methods.
The six species, C. erectus, Q. virginiana, T. bicolor, B. buceras, C. viridis and C.

58

hypericifolia, with anti-QS activity determined using the C. violaceum assay were then
analyzed using an A. tumefaciens assay (Figure 2.2b and Table 2.2). Control discs
containing halogenated furanone, tetracycline, and ethanol were included. As expected, a
zone of growth inhibition was observed with tetracycline, a zone of QS inhibition was
seen with the furanone, and no inhibition was apparent with ethanol (Figure 2.2a).

Figure 2.2 Anti-QS activity using (a) C. violaceum and (b) A. tumefaciens strains. AntiQS activity was tested using 20 µL of water extracts of (1) C. erectus, (2) B. buceras, (3)
C. viminalis-leaf, (4) C. viminalis-infloresence, (5) T. bicolor, (6) C. hypericifolia, and
(7) Q. virginiana (7). Also included as controls were (8) 10 µg gentamycin (a) and
tetracycline (b), (9) 20 µl ethanol, and (10) halogenated furanone. Discs 11 – 17 contain
20 µL of ethanolic extracts of (11) C. erectus, (12) B. buceras, (13) C. viminalis-leaf,
(14) C. viminalis-infloresence, (15) T. bicolor, (16) C. hypericifolia, and (17) Q.
virginiana.
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Again, strong anti-QS activity was observed in both the water and ethanol extracts
of C. erectus, C. viminalis (inflorescence), B. buceras, and T. bicolor (Figure 2.2b and
Table 2.2). With C. erectus, C. viminalis (leaf), and Q. virginiana the water extracts were
more effective than those in ethanol.

Extracts of B. buceras and C. viminalis

(inflorescence) produced similar-sized halos regardless of solvent, whereas T. bicolor and
C. hypericifolia showed higher activity as ethanol extracts. None of the biomonitor
strains detected any activity with a C. hypericifolia water extract (Table 2.2).

Table 2.2 Species showing anti-QS activity in this study
Active Plant Species
Conocarpus erectusa

Part Tested Solvent
Leaves
H2O
EtOH
Bucida burcerasa
Leaves
H2O
EtOH
Callistemon viminalis
Leaves
H2O
EtOH
Callistemon viminalis
Infloresence H2O
EtOH
Tetrazygia bicolor
Leaves
H2O
EtOH
Chamaesyce hypericifolia Aerial
H2O
EtOH
Quercus virginiana
Leaves
H2O
EtOH

% Yield
14.1
12.3
12.9
13.9
14.3
21
23.2
28
22.5
16
12.2
13.2
11.2
13.2

b

Zone of QS Inhibition (mm)c
CV CVO26 NTL4 C6 NTL4 C12
8.7
4.7
8.2
6.4
5.9
2.1
6.2
4.3
8.3
5.4
8.6
8.9
8
3.2
8.4
9
4.4
1.5
4.2
3.6
1.7
0
1.7
2
7
3.4
6.9
6.9
5.2
2.1
5.9
6.3
5.7
2.2
5.8
5.4
6.2
2.2
6.4
5.5
0
0
0
0
3.9
2.1
4.2
5.6
4
2
4.9
3.5
1.2
0
2.3
1.2

a

Species marked that showed slight antibacterial activity in addition to anti-QS.

b

Percent yield and zone of QS inhibition for water (H2O) and ethanolic extracts (EtOH).

c

Average zones of QS inhibition using three biomonitor strains: Chromobacterium

violaceum ATCC #12472 (CV), C. violaceum CVO26 (CVO26), and Agrobacterium
tumefaciens NTL4 with added C6-AHL (NTL4 C6) or C12-AHL (NTL4 C12). Average
zones of killing for 10 μg Gm and 10 μg Tc were 9.3 and 18.8 mm, respectively.
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2.4.4 Antibacterial vs. anti-quorum sensing activity
The halos produced on lawns of the biomonitor strains could be the result of
either (i) inhibition of cell growth or (ii) quenching of QS signals. Growth inhibition
would produce a clear halo versus a turbid halo for the latter. To differentiate, the halo
was examined under a higher magnification (Figure 2.3). As expected, the presence of the
antibiotic gentamycin, created a clear zone of inhibition suggesting bactericidal activity.
Under the same magnification, the area surrounding a disk containing crude extract of C.
erectus showed normal cell growth.

Figure 2.3 Antibacterial activity vs. anti-QS activity. Magnification of the areas
surrounding (a) a gentamycin (Gm) disc, and (b) a disc containing ethanolic extract of C.
erectus. The area around the disk in (a) is clear of cells, whereas in (b) there is a
confluent layer of bacteria which lose their ability to produce violacein (anti-QS effect) in
proximity to the disk.

The halo-effect is created by pigmentless (QS interrupted) cells adjacent to the
disk, and the presence of violacein-producing (QS active) cells further out. In both C.
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violaceum and A. tumefaciens assays, C. erectus and B. burceras had antibacterial
activity (zone of inhibition 1- 2 mm) in addition to anti-QS activity (Figure 2.1). This
activity was more pronounced with the A. tumefaciens biomonitor strain.

2.5 Discussion and conclusions
The aim of this study was to determine the anti-QS potential of southern Florida
medicinal plants as a means to uncover a potential mode of action and to suggest a
validation for continued traditional use. To date, research has shown anti-QS activity in
only a few higher plants and seaweed (Fray, 2002; Gao et al., 2003; Manefield et al.,
1999; Teplitski et al., 2000). This study introduces six medicinal plant species having
anti-QS activity, representing five different families: C. erectus (Combretaceae), Q.
virginiana (Fagaceae), B. buceras (Combretaceae), C. viminalis (Myrtaceae), T. bicolor
(Melastomataceae), and C. hypericifolia (Euphorbiaceae) (Table 2.2).

Our findings

suggest that the anti-QS activity of plants on bacteria is perhaps more ubiquitous and
diverse than previously thought.
Screening for anti-QS activity using multiple biomonitors (Table 2.2) eliminates
artifact effects.

If a plant showed activity with a C. violaceum strain and not A.

tumefaciens, this activity might be limited to an aspect of violacein production
downstream of the QS system. In contrast, if a sample had activity with A. tumefaciens
and C12-AHL only, it might be limited to an effect on long chain signaling molecules.
Since the six active species were effective at inhibiting QS in all biomonitor strains, we
can assume that the responsible compounds have multiple or broad-spectrum effects.
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The preliminary screen provided some insight as to the effect of preparation on
activity, something not often accounted for in medicinal plant studies. Leaves with
excessive microbial colonization resulted in false-positive results. Therefore, care should
be taken to eliminate bacterial and fungal causes of activity. An anti-QS effect was seen
only in macerated leaves, suggesting that these compounds are not secreted on the leaf
surface. Drying and extracting also affects efficacy in some cases, again indicating the
importance of preparation. Hot water and ethanolic extracts were tested, as opposed to
organic solvents, providing greater congruity with traditional preparation methods.
C. erectus, B. buceras, and T. bicolor have the highest anti-QS activities (Table
2.2). Commonly known as buttonwood, C. erectus is mainly used in southern Florida as
an ornamental. The bark of this tree has been used for tanning leather and as a piscicide.
Leaves are eaten or made into a decoction and taken for fever in parts of Africa and
Puerto Rico (Burkhill, 1985; Irvine, 1961; Melendez, 1982). Buttonwood has also been
used against catarrh, conjunctivitis, diarrhea, syphilis, and gonorrhea (Morton, 1981;
Nellis, 1994). B. buceras is also used for syphilis and gonorrhea (Morton, 1981). A leaf
decoction of T. bicolor is used in the Bahamas to treat “night sweats” (Morton, 1981),
though it is unclear whether this ailment requires an analgesic or antibacterial treatment.
The water and ethanol extracts of C. viminalis inflorescences and the water
extract from C. viminalis leaves have strong anti-QS activity (Table 2). The essential oil
of C. viminalis has antihelminthic properties (Garg & Kasera, 1982). Leaf decoctions,
from species of the closely related genus Melaleuca, are used against a number of skin
and respiratory conditions in the Bahamas, Puerto Rico, and Indochina (Duke, 1985;
Melendez, 1982; Morton, 1981). Tea tree oil, M. alternifolia, has a long history of use in
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traditional medicine, and is a proven antimicrobial (Halcon & Milkus, 2004; Hammer et
al., 1996).
The water extract from Q. virginiana leaves exhibited more activity than its
ethanol extracts. A bark decoction of Q. virginiana was used by Native Americans in the
treatment of dysentery (Moerman, 1998). and in Cuba as a febrifuge and antiseptic
(Morton, 1981).

The extracts from Q. virginiana leaves and bark were applied

externally, as an astringent analgesic to treat pain, sores, and hemorrhoids (Moerman,
1998).
Only the ethanol extracts of C. hypericifolia exhibited anti-QS activity, suggesting
the active components are either significantly less polar than water, or that they are heat
labile. In Guadalupe, C. hypericifolia is used to treat abrasions, opthalmia, diarrhea,
respiratory ailments, and dysentery (Duke, 1985).

It is also used in the Bahamas as a

remedy for leucorrhea (Morton, 1981). A related species, C. hirta, has numerous
medicinal uses in the Old World tropics and in the British Pharmacopoeia (Morton,
1981). It is used in Puerto Rico and many South American countries against fever,
bronchitis, gonorrhea, and intestinal parasites (Bennett et al., 2002; Melendez, 1982).
Both C. erectus and B. buceras possess antibacterial as well as anti-QS activity.
This poses the question of whether reduced concentrations of antibacterial compounds
can create an anti-QS effect by reducing the cell count to a number below the quorum.
Although it cannot be completely ruled out, in the case of two common antibiotics
(tetracycline, gentamycin) this proved untrue. With both antibiotics, there was a distinct
change from the zone of inhibition to viable cells. There was no loss of pigment in the
cells immediately surrounding the kill zone, and in fact there was a ring of darker color.
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It is unclear at this stage whether the antibacterial and anti-QS effect in these plants are
from the same or distinct chemical compounds.
Differential TLC migration suggests that more than one compound may
contribute to anti-QS effect in these plants (data not shown). These compounds also
seem distinct from those produced in bacteria and seaweed. To date the only known antiQS compounds from higher organisms are structural mimics (Manefield et al., 1999;
Manefield et al., 2002). However, quorum quenching can occur through a number of
other methods including signal binding, degradation, or direct interaction with QS genes
(Smith & Iglewski, 2003b). We are currently focusing on chemical identification of the
anti-QS compounds in the screened efficacious extracts using chromatographic methods
and mass spectrometry.
In summary, the anti-QS potential of medicinal plants may be as important as the
antibacterial effect. In this study, we have shown six medicinal plants from southern
Florida to have anti-QS activity. We propose that the anti-QS effect of the plants
reported could contribute in part to their efficacy and traditional use as medicines. Most
recent studies test only the antibacterial effect of plants used to treat infection leaving
useful plant species to go unnoticed (e.g.: (Bonjar, 2004; Hernandez et al., 2003; Kloucek
et al., 2005; Mothana & Lindequist, 2005; Romero et al., 2005)). We suggest that other
mechanisms of action, including anti-QS activity, should not be overlooked. Although
biomonitor strains were chosen for ease of screening, similar QS systems exist in many
human pathogens. Future work will focus on the effect of anti-QS compounds in these
model organisms.
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3.1 Abstract
Quorum sensing (QS) is a key regulator of virulence and biofilm formation
in Pseudomonas aeruginosa and other medically relavent bacteria. Aqueous extracts of
six plants: Conocarpus erectus, Chamaesyce hypericifolia, Callistemon viminalis, Bucida
buceras, Tetrazygia bicolor, and Quercus virginiana were examined in this study for
their effects on P. aeruginosa virulence factors and the QS system. C. erectus, B.
buceras, and C. viminalis cause significant inhibition of LasA protease, LasB elastase,
pyoverdin production, and biofilm formation. Additionally, each plant presents a distinct
profile of effect on the las and rhl QS genes and their respective signaling molecules,
suggesting different mechanisms responsible for efficacy. Extracts of all plants caused

inhibition of QS genes and QS-controlled factors with marginal effects on bacterial
growth, suggesting quorum quenching mechanisms unrelated to static or cidal effects.

Keywords: Quorum sensing, medicinal plants, virulence factor, Pseudomonas
aeruginosa, LasA, LasB, pyoverdin, biofilm

Abbreviations: QS, Quorum Sensing; AHL, Acyl-Homoserine Lactone; OdDHL, N-(3oxododecanoyl)-L-homoserine lactone; BHL, N-butanoyl-L-homoserine lactone; AB,
Agrobacterium Broth (minimum media); LB Luria-Bertani broth
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3.2 Introduction
Pneumonia due to microbial infections is a major cause of morbidity and
mortality in immuno-compromised patients. Pseudomonas aeruginosa hails as the
leading pathogen among patients suffering from cystic fibrosis, diffused pan-bronchitis,
and chronic obstructive pulmonary disease (Hoiby, 1994; Lieberman, 2003; Registry,
2005). In addition, P. aeruginosa remains one of the major causes of nosocomial
infections (Centers for Disease Control and Prevention, 2004). The success of this
organism is largely due to the production of a myriad of virulence factors (including
LasA protease, LasB elastase, pyoverdin, pyocyanin, and alginate) and its capability to
form intractable biofilms (Lyczak et al., 2002).
Expression of many of the virulence factors in P. aeruginosa is controlled by the
quorum sensing (QS) system (Venturi, 2006), an intercellular communication scheme in
which bacteria are able to detect population density (via signaling molecules and
receptors) and control gene expression accordingly (Schuster & Greenberg, 2006).

P.

aeruginosa elaborates two main sets of QS systems: lasI-lasR and rhlI-rhlR (Schuster &
Greenberg, 2006). LasI and RhlI are synthetases that manufacture the autoinducer
signaling molecules N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL) and Nbutanoyl-L-homoserine lactone (BHL), respectively. These molecules diffuse out into
the environment and, upon reaching a putative threshold concentration, activate receptors
lasR and rhlR. These receptors, in turn, coordinate regulation of pathogenicity. A third
signal, PQS (Pseudomonas Quinolone Signal), also plays an integral role in the QS
system (Pesci et al., 1999). This secondary metabolite of P. aeruginosa is incorporated
into the QS hierarchy in times of cell stress (McKnight et al., 2000). This intricate
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communication system of P. aeruginosa is mirrored in many gram-negative pathogenic
bacteria, where it coordinates regulation of virulence, including motility, biofilm
formation, and toxin production (De Kievit & Iglewski, 2000; Donabedian, 2003; Fuqua
& Greenberg, 1998; Parsek & Greenberg, 2000; Schauder & Bassler, 2001).
The misuse and abuse of antibiotics in pharmacotherapy has led to the
development of widespread resistance in the target organism. The failure of existing
antibiotics to control infection makes it crucial to find alternatives to currently available
drugs. Since pathogenicity in many bacteria is regulated by QS, inhibition of this system
may cause attenuation of virulence and protect against infection (Hentzer & Givskov,
2003; Juhas et al., 2005; Smith & Iglewski, 2003a). In fact, an anti-QS approach has
already shown promise in the battle against P. aeruginosa (Hentzer et al., 2003; Wu et
al., 2004).
Anti-QS agents were first characterized in the red marine alga, Delisea pulchra,
(Manefield et al., 1999; Manefield et al., 2002) and more recently, in a South Florida alga
(Cumberbatch, 2002) and a few higher plants (Bjarnsholt et al., 2005; Gao et al., 2003;
Teplitski et al., 2000).

It has been shown that terrestrial plants not only produce

autoinducer mimics to confound the bacterial QS system, but receive and respond to
microbial signals as well (Adonizio et al., 2006; Bauer & Mathesius, 2004). Given the
promise of anti-QS compounds, efficient screening for these agents becomes imperative.
In a previous study we utilized an ethnobotanically-directed search for anti-QS activity
(Adonizio et al., 2006). We confirmed six South Florida medicinal plants: Conocarpus
erectus, Chamaesyce hypericifolia, Callistemon viminalis, Bucida buceras, Tetrazygia
bicolor, and Quercus virginiana to have anti-QS properties using Chromobacterium
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violaceum and Agrobacterium tumefaciens NTL4 biomonitor strains (Adonizio et al.,
2006). These plants were chosen based on traditional use against respiratory and skin
infections, conditions potentially caused or complicated by bacteria such as Pseudomonas
aeruginosa.
Here we have taken this work a step further by exploring the effect of these six
plants on the production of virulence factors and biofilms, AHL levels, and QS gene
transcription in this organism. We demonstrate a significant decrease in the production
of LasA protease, LasB elastase, pyoverdin, and biofilms in the presence of the extracts.
Furthermore, each plant has a unique pattern of effect on the QS genes lasI/R and rhlI/R
and their respective signaling molecules OdDHL and BHL.

3.3 Materials and methods
3.3.1 Plant extraction
Conocarpus erectus (Combretaceae), Chamaesyce hypericifolia (Euphorbiaceae),
Callistemon viminalis (Myrtaceae) (inflorescence), Bucida buceras (Combretaceae),
Tetrazygia bicolor (Melastomataceae), and Quercus virginiana (Fagaceae), were
collected and processed according to methods described previously (Adonizio et al.,
2006). Briefly, pulverized plant material was extracted into boiling water, freeze-dried
using a lyophilizer, and stored at -20 °C until needed. Leaf extracts were tested unless
otherwise noted. To complement the six active plants from the previous study, an
additional plant with no anti-QS activity was chosen (Schefflera actinophylla, Apiaceae)
as a negative control.
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3.3.2 Strains and media
Prototypic P. aeruginosa strain PAO1 (Holloway & Morgan, 1986), and its
derivatives (Kong et al., 2005) were used throughout this study.

In addition,

Staphylococcus aureus (ATCC # 12600) was used in the LasA assay. Cells were
maintained on Luria-Bertani broth (LB) plates and in LB liquid for overnight cultures.
For quantitative assays, either LB (LasA assay only) or AB minimum media (added
glucose and casein amino acids (20% w/v) was used (Clark & Maaloe, 1967).

3.3.3 Culturing conditions
For all assays except biofilm formation, culture conditions were as follows.
Overnight cultures of PAO1 were grown in LB at 37 °C with shaking. Cultures were
then diluted 100-fold into AB or LB media and allowed to grow to an OD600 of 1.7 (early
stationary phase). At this point, the culture was divided into 10 ml aliquots, and an
additional 1 ml of fresh media containing crude plant extract (or media control) was
added to a final concentration of 1 mg/ml extract. Cultures were recovered at late
stationary phase (approximately 12 hours after addition). Cells were separated from the
growth media by centrifugation at 10,000 x g for 10 minutes.

3.3.4 LasA staphylolytic assay
LasA protease activity was determined by measuring the ability of culture
supernatants to lyse boiled S. aureus cells (Kong et al., 2005). A 100 μl aliquot of P.
aeruginosa LB culture supernatant with or without plant extracts was added to 900 μl of
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boiled S. aureus suspension. OD600 was determined after 0, 5, 10, 20, 30, 45, and 60
minutes. Activity was expressed as ∆OD600 / hour per μg protein.

3.3.5 LasB elastolytic assay
The elastolytic activity of AB culture supernatants was determined using elastin
Congo red (ECR; Sigma, St. Louis, MO)(Ohman et al., 1980). A 100 μl aliquot was
added to 900 μl of ECR buffer (100 mM Tris, 1 mM CaCl2, pH 7.5) containing 20 mg
ECR. This was then incubated with shaking for 3 hours at 37 °C. Insoluble ECR was
removed by centrifugation, and the absorption of the supernatant was measured at 495
nm. Cell-free AB medium, alone, and with plant extracts were used as negative controls.
Activity was expressed as ∆OD495 per μg protein.

3.3.6 Pyoverdin assay
The pyoverdin assay was adapted from the methods of Cox and Adams (Cox &
Adams, 1985). The AB supernatant was diluted tenfold into Tris-HCl buffer (pH 7.4),
and 100 μL aliquots were added to 96-well microtiter plates on ice. Relative
concentration of pyoverdin was based on fluorescence of the supernatant at an excitation
wavelength of 405 nm and an emission wavelength of 465 nm (Thurion Genious
FluorSpec). Activity was expressed in relative fluorescence units (RFU). Although we
consider pyoverdin to be a marker of QS, a drop in production may be due to an indirect
effect via pH or iron concentration changes (Jacques et al., 2003). To eliminate the
chance of false positives, iron concentration was tested using 1,10-phenanthroline and
desferal (Yegorov et al., 1993), and solution pH was checked throughout the experiment.
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3.3.7 Polyvinyl chloride (PVC) biofilm formation assay
The effect of plant extracts on the attachment phase of biofilm formation was
measured using the PVC biofilm formation assay (O'Toole & Kolter, 1998). Briefly,
overnight cultures of PAO1 were resuspended in fresh AB medium in the presence and
absence of plant extracts. After a 10 hour incubation period at 30 °C, biofilms were
visualized in the microtiter plates by staining with a crystal violet solution. Plates were
rinsed to remove planktonic cells, and surface-attached cells were then quantified by
solubilizing the dye in ethanol and measuring absorbance at OD650 nm.

3.3.8 AHL assay
AHLs were extracted from AB culture supernatants with acidified ethyl acetate,
dried under nitrogen, and quantified by electrospray mass spectroscopy (ESMS) after the
methods of Makemson et al (Makemson et al., 2006). Peak intensities for BHL (m/z =
172) and OdDHL (m/z = 298), and their sodium adducts (m/z= 194 and 230 respectively)
were combined and converted to concentration using a standard curve generated from the
pure compounds. Background readings from samples extracted with alkaline ethyl acetate
were subtracted from those of the acid-extracted bacterial cultures before conversion, as
the lactone ring is broken by alkaline hydrolysis making AHLs too polar to be fully
extracted into ethyl acetate.

3.3.9 Growth curves
The effect of plant extracts on cell proliferation was determined by monitoring of
the PAO1 growth curve. Briefly, an overnight culture (LB) of PAO1 was diluted 100-
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fold into 1 L AB or LB media. OD600 was monitored at 45-minute intervals until an
OD600 of ~1.7 (approximately 8 hours). The culture was then divided into 28 ml aliquots,
to which 2 ml of AB or LB (controls) or 2 ml concentrated extract were added. The final
extract concentration was 1 mg/ml. Cultures with added extract were normalized to the
control OD600 of 1.7 at this time to account for plant pigmentation. Optical density was
monitored at 1.5 hour intervals until a final time point of 24 hours.

All OD600

measurements were verified at 1/10 dilution for greater accuracy.

3.3.10 β-Galactosidase assay
Transcriptional activity of QS-gene promoters was assayed using PAO1-derived
strains harboring promoter-lacZ fusions: PlasI-lacZ (pPCS223), PlasR-lacZ (pPCS1001),
PrhlI-lacZ (pLPR1), PrhlR-lacZ (pPCS1002), and as a control, a promoterless-lacZ fusion
strain (pLP170) (Kong et al., 2005). Cultures were grown in AB media and monitored
under the same conditions as PAO1, with extract added once the cultures reached an
OD600 of 1.7. Assays for β-galactosidase activity in P. aeruginosa were performed using
ONPG as previously described (Mathee et al., 1997).

3.3.11 Bradford assay
In addition to growth curve monitoring, the Bradford assay (Bradford, 1976) was
performed to confirm that the reduction in virulence factors was not due to a decrease in
cell density. Raw data from all assays were normalized to total protein concentration;
however, there was no significant difference between sample sets.
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3.2.12 Statistical analysis
All experiments were performed independently in triplicate on pooled samples of
biological replicates described in Adonizio et al 2006 (Adonizio et al., 2006). Data were
analyzed using one-way analysis of variance (ANOVA) with a P-value of 0.05 using the
statistical software package SPSS (Chicago, IL).

3.4 Results3.4.1 LasA protease activity in the presence of plant extracts
LasA staphylolytic protease is a 20-kDa zinc metalloendopeptidase belonging to
the β-lytic endopeptidase family of proteases (Kessler, 1995). There was a significant
decrease in LasA activity when PAO1 was grown in the presence of B. buceras (96%
decrease), C. erectus (94% decrease), T. bicolor (89% decrease), C. viminalis (71%
decrease), or C. hypericifolia (49% decrease) when compared to the control (Table 3.1).
Addition of Q. virginiana, had no significant effect on LasA protease production. As
expected, the negative control, S. actinophylla, also showed no significant change in
LasA activity (Table 3.1).

3.4.2 LasB elastase activity in the presence of plant extracts
LasB elastase is a zinc metalloprotease capable of destroying or inactivating a
wide range of biological tissues and immunological agents (Bever & Iglewski, 1988).
There was a significant decrease in LasB activity when PAO1 was grown in the presence
of C. erectus (65% decrease) or C. viminalis (63% decrease), when compared to the
control. Growth of PAO1 with B. buceras, T. bicolor, or S. actinophylla (negative
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control) caused no significant effect, whereas C. hypericifolia, and Q. virginiana caused
an increase in elastase activity.

Table 3.1 Effect of plant aqueous extracts on P. aeruginosa virulence factors
Culture conditions

LasA activitya

Elastase activityb

Pyoverdin productionc

Biofilm formationd

Media only

0.274 ± 0.016

145.5 ± 6.9

4918 ± 281

0.64 ± 0.01

C. erectus

0.017 ± 0.005*

48.2 ± 11.8*

453 ± 85*

0.38 ± 0.19

B. buceras

0.010 ± 0.011*

130.8 ± 31.5

800 ± 275*

0.14 ± 0.01*

C. viminalis

0.080 ± 0.004*

53.9 ± 4.2*

1997 ± 271*

0.07 ± 0.01*

T. bicolor

0.030 ± 0.015*

105.6 ± 14.3

2134 ± 304*

0.13 ± 0.02*

Q. virginiana

0.197 ± 0.012

499.1 ± 36.0

4423 ± 422

0.08 ± 0.03*

C. hypericifolia

0.139 ± 0.012*

553.6 ± 19.4

3068 ± 295*

0.70 ± 0.07

S. actinophylla

0.224 ± 0.014

172.4 ± 9.2

4069 ± 611

0.53 ± 0.16

a

LasA activity was expressed as reduction in OD600 per hour per microgram total protein

b

Elastase activity was expressed as absorbance at OD495 per microgram of protein * 1000

c

Pyoverdin production was expressed as fluorescence at 465 nm (excitation λ=405 nm)

per microgram of protein
d

Biofilm production was expressed as OD650 after incubation with crystal violet

*Indicates significance at p=0.05
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3.4.3 Extracts alter pyoverdin production
Pyoverdins are virulence factors in that they compete with mammalian transferrin
for iron, the successful sequestration of which essentially starves the host tissues (Meyer
et al., 1996). They also promote pathogenicity by stimulating bacterial growth (Cox &
Adams, 1985). One of the pyoverdins is suggested to be a QS-like molecule, regulating
both itself and production of other toxins (Beare et al., 2003; Lamont et al., 2002). All
plant extracts with the exception of Q. virginiana and S. actinophylla (negative control),
showed a significant reduction of pyoverdin production; however, C. hypericifolia was
only marginally significant (Table 3.1). The most active extracts were C. erectus and B.
buceras, with a substantial decrease in pyoverdin activity (91% decrease and 84%
decrease respectively) when compared to the control (Table 3.1). All of the culture
supernatants retained a pH of ~7.0 regardless of amount or type of extract added.
Although statistically significant differences were found between iron concentration in
the extracts, there was no trend which could be correlated with activity on pyoverdin
(data not shown).

3.4.4 Plant extracts have an inhibitory effect on biofilm formation
P. aeruginosa has the ability to form biofilms, a partially QS controlled
phenomenon (Davies et al., 1998), where cells are organized into layers, and enmeshed in
a matrix of mucoid polysaccharides (Costerton, 1995). A switch to the biofilm mode of
growth confers increased antibacterial resistance and creates a considerably more severe
infection in the cystic fibrosis lung (Lyczak et al., 2002). There was a significant
decrease in biofilm formation when PAO1 was grown in the presence of C. viminalis
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(89% decrease), Q. virginiana (88% decrease), T. bicolor (80% decrease), or B. buceras
(78% decrease) when compared to the control (Table 3.1). C. erectus caused a 41%
decrease in biofilm formation; however, this result was marginally insignificant.

3.4.5 Plant extracts affect QS gene expression
With the exception of Q. virginiana, C. hypericifolia, and the negative plant
control S. actinifolia, most extracts had a significant effect on QS gene expression (Table
3.2). The most significant decreases in lasI expression were found with C. viminalis
(80% decrease), B. buceras (49% decrease), T. bicolor (41% decrease), and C. erectus
(38% decrease).

C. erectus and C. viminalis show the greatest reduction of lasR

expression (56% and 48% decrease, respectively). Whereas T. bicolor (42% decrease),
B. buceras (55% decrease), and C. erectus (40% decrease) show the greatest reductions
in rhlI expression. These same three plants also affect the greatest reductions in rhlR
expression (66%, 62%, and 66% decrease respectively).

3.4.6 Plant extracts affect the production of AHL molecules
Notable decreases in OdDHL levels were seen with C. viminalis (46% reduction
from the control) and B. buceras (38% reduction). Significant decreases in BHL levels
corresponded to the addition of B. buceras, T. bicolor, and C. hypericifolia extract, with
reductions of (41%, 39%, and 35%, respectively) (Table 3.2).
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Table 3.2 Effect of plant extracts on P. aeruginosa QS genes and AHL production
AHL Productiona

Gene Expressionb

Culture conditions
C12-AHL

C4-AHL

lasI

lasR

rhlI

rhlR

Media only

1.216 ± 0.19 0.789 ± 0.10 3363 ± 311 5008 ± 256 4855 ± 459 8271 ± 655

C. erectus

0.981 ± 0.14 0.597 ± 0.01 2101 ± 270* 1489 ± 102* 2917 ± 265* 3004 ± 406*

B. buceras

0.751 ± 0.16x 0.468 ± 0.12* 1718 ± 147* 2377 ± 179* 2200 ± 249* 3339 ± 440*

C. viminalis

0.659 ± 0.15* 0.533 ± 0.02* 662 ± 86* 1745 ± 182* 3370 ± 300* 3751 ± 120*

T. bicolor

1.501 ± 0.29 0.483 ± 0.03* 2000 ± 183* 2038 ± 202* 2810 ± 449* 2930 ± 282*

Q. virginiana

1.041 ± 0.19 0.586 ± 0.09 2806 ± 204 3374 ± 460* 3128 ± 299* 5324 ± 306*

C. hypericifolia

0.892 ± 0.02 0.511 ± 0.08* 2765 ± 249 3324 ± 97* 3433 ± 412* 3635 ± 319*

S. actinophylla

1.146 ± 0.17 0.761 ± 0.10 3715 ± 363 4692 ± 200 4748 ± 181 7347 ± 628

a

AHL production was expressed in µM

b

Gene expression was measured via β-galactosidase activity of the lacZ gene fusion

products and expressed as Miller Units
*Indicates significance at p=0.05

x

Indicates significance at p=0.10

3.4.7 Extracts have minimal effect on PAO1 growth after log phase
Addition of extract at early stationary phase was chosen to limit any confounding
effects on growth. When extracts were added at the beginning of the cell cycle (time
zero), there were changes (slight delay or acceleration) in the logarithmic phase (data not
shown). This did not, however, impact the endpoint cell density in most cases. To
confirm an anti-QS mode of action, rather than logarithmic changes, a growth curve was
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taken controlling for the latter (Figure 3.1). Cultures of PAO1 were grown to early
stationary phase before addition of compound (Figure 3.1, arrow). This insures that all
samples would have the same opportunity (length of time and cell density) to reach the
point of QS-controlled production of virulence factors. Stationary phase was reached in
all samples (including control) approximately 8 hours after extract addition. Addition of
extract did not significantly affect cell density or total protein.

Figure 3.1 Influence of medicinal plant extracts on growth of P. aeruginosa (semi-log
graph).

Extracts were added during early stationary phase (approximately 8 hours)

indicated by arrow.

The data represent mean values of experiments performed in

triplicate.
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The majority of the samples have little effect on the growth curve of PAO1 after
log phase (Figure 3.1). The growth curve with added T. bicolor closely follows that of
the media-only control, whereas Q. virginiana, B. buceras, C. hypericifolia, Q.
virginiana, C. erectus and S. actinophylla all exhibit a slight increase in cell density
(Figure 3.1). This increase is not significant, and is possibly due to added nutrients.
However, it verifies that the anti-QS effect of these plants is not due to cell death.
Incidentally, addition of T. bicolor and Q. virginiana at time zero resulted in cell
densities below the control (data not shown). This suggests an additional antibacterial
effect of these plant extracts. However, total protein (measured via Bradford assay) of
these samples did not differ significantly from the control.

3.5 Discussion
Six South Florida medicinal plants, C. erectus (Combretaceae), C. hypericifolia
(Euphorbiaceae), C. viminalis (Myrtaceae), B. buceras (Combretaceae), T. bicolor
(Melastomataceae), and Q. virginiana (Fagaceae), were examined for their anti-QS
activity against P. aeruginosa PAO1. The virulence of P. aeruginosa is owed to its
capacity to degrade host tissue with proteases and toxins, and to evade antibiotic attack
by forming biofilms. Biofilm formation and the virulence factors examined in this study
are under QS control (Davies et al., 1998; Kharazmi, 1989; Meyer et al., 1996; Morihara
& Homma, 1985). Thus, the plant extracts were examined for their ability to interfere
with QS-dependent production of P. aeruginosa virulence factors LasA, LasB, and
pyoverdin. In addition, we examined the ability of the extracts to inhibit biofilm
formation, QS gene expression, and AHL synthesis.
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3.5.1 Plant extracts differentially affect biofilm formation
Since QS is involved in biofilm formation (Davies et al., 1998), we expected the
plants posessing anti-QS activity to have a significant effect. Indeed, all extracts tested
affected a decrease in biofilm formation, with the exception of C. hypericifolia.
Interestingly, Q. virginiana exhibited an effect on biofilm production, though no other
virulence factors, suggesting either a physical inhibition of biofilm growth or repression
of biofilm genes and components outside the QS system. Disruption of the QS system
using furanones has also been shown to inhibit biofilm growth (Hentzer et al., 2002).
Previous work with garlic and D. pulchra furanones showed a qualitative change in
biofilm morphology and a reduction in thickness; however, these analyses were not
quantified (Hentzer et al., 2002; Hentzer et al., 2003; Rasmussen et al., 2005).

3.5.2 Plant extracts differentially affect production of virulence factors
P. aeruginosa proteases LasA and LasB are believed to play a major role in
pathogenesis via host tissue degradation (Kharazmi, 1989; Morihara & Homma, 1985).
With the exception of Q. virginiana, all other plant species resulted in a significant
decrease in the LasA activity of P. aeruginosa, with the most drastic reductions seen in B.
buceras, C. erectus, and T. bicolor. No prior studies have considered LasA activity in the
presence of anti-QS compounds.
The LasB elastase activity was significantly reduced in the presence of C. erectus
and C. viminalis. Extracts from B. buceras and T. bicolor had no significant effect,
whereas C. hypericifolia and Q. virginiana caused an increase in elastase activity. It is
likely that the compounds in the latter two plants may upregulate the production of LasB

83

and/or enhance the elastase activity. The compounds are not likely to be elastase-like
proteins in the plants since the extraction process would have denatured most proteins. In
comparison, recent studies on garlic (at 2% v/v) show a 50% decrease in LasB activity
(Rasmussen et al., 2005), whereas purified halogenated furanone from D. pulchra (10
μM) induces an approximate 90% decrease (Hentzer et al., 2003).
All plant extracts, with the exception of Q. virginiana, caused a significant
reduction of pyoverdin production. Mixed results on pyoverdin production have been
previously observed with furanones. A naturally-occurring furanone from D. pulchra
((5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone)
production of pyoverdin (Sakar et al., 2005).

actually

increases

Whereas furanone C-30, a synthetic

derivative of a compound from D. pulchra, confers a 90% reduction in pyoverdin levels
(Hentzer et al., 2003). Neither iron-limitation nor pH is sufficient to explain the effect on
virulence factor production. There were also no significant changes in cell growth
corresponding to pyoverdin production, leaving anti-QS effect as the most plausible
hypothesis.

3.5.3 Mechanistic musings: multiple targets or global effect.
Quorum inhibition occurs via a number of different mechanisms, the most well
known being signal mimicry, such as in the case of the furanones (Manefield et al., 1999;
Manefield et al., 2002). Other methods include signal degradation by proteins such as
lactonase or acylase (Dong et al., 2001), signal binding, inhibition of genetic regulation
systems, or interruption of downstream virulence and biofilm genes (for a review see
(Whitehead et al., 2001b)).
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The current view of the P. aeruginosa QS hierarchy suggests that las controls rhl
with virulence proteins at the bottom of the ladder (Schuster & Greenberg, 2006). The
virulence factors LasA (staphylolytic protease) and LasB (elastase) are generally thought
to be under control of the lasI/R system (Gambello, 1991; Schuster & Greenberg, 2006),
however rhlI/R also controls activity to a lesser extent (Brint & Ohman, 1995; Pearson et
al., 1997). Pyoverdin is believed to be under rhlI/R control (Brint & Ohman, 1995;
Whiteley, 1999), whereas biofilm production is only partially under QS control (Davies
et al., 1998). The redundant and auto-regulatory nature of the QS system is quite
convoluted (Van Delden & Iglewski, 1998).

This, compounded with the complex

phytochemistry of plant extracts prevents us from precisely linking QS gene expression,
AHL level, and virulence factor production.
Although the mechanism of action of these extracts is a complex problem, there is
an overall inhibition of the QS system with each of the tested plant extracts (with the
exception of the control S. actinifolia). This somewhat general effect points to one of
two explanations. The first, suggests that multiple chemicals in the plants may be causing
distinct effects on different aspects of the QS system. The second explanation is that the
effect is not directly on the las/rhl system, but rather on a more global QS regulator such
as Vfr (Albus et al., 1997) or GacA (Reimmann et al., 1997).
There is also a trend in which the plant species that have less of an effect on AHL
production and las/rhl expression also have less activity on P. aeruginosa virulence
factors. This is most clearly seen with Q. virginiana, C. hypericifolia, and the control, S.
actinifolia (Tables 3.1 and 3.2). Although not absolute, the converse is generally true.
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Overall, the most significant effects on the QS system were found with C. viminalis, B.
buceras, and C. erectus.
Distinct patterns of thin layer chromatography (TLC) migration in these three
extracts (data not shown) suggest that they contain multiple active compounds, perhaps
functioning with separate mechanisms. At this point we do not have sufficient data to
pinpoint the method of quorum quenching, we will therefore withhold further
mechanistic speculation until these compounds are purified from the plants.

3.6 Conclusions
In summary, this work presents six plant species, representing five distinct
families, which have a differential but significant effect on virulence factors, biofilms,
QS gene expression, and signal production at a concentration of 1 mg/ml.

This

concentration, although high, is relevant to traditional medicinal use in teas and poultices.
More significantly, this concentration represents a crude aqueous extract and therefore
should be much lower as a putative anti-QS compound. Concentrations were tested down
to 0.25 mg/ml, and some extracts, notably that of C. erectus, still had an effect on
virulence factor production (unpublished results).
None of the plant extracts tested had a significant effect on the growth of PAO1
when added at early stationary phase (Figure 3.1, arrow). However, addition of T.
bicolor and Q. virginiana at time zero resulted in cell densities below the control (data
not shown), which suggests an additional antibacterial effect of these plants. All other
plant extracts significantly reduced one to four QS-controlled virulence factors, genes,
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and AHL levels without a reduction in growth. This would strongly suggest an anti-QS
rather than an antibacterial effect.
The top candidates for further anti-QS investigation are C. erectus, B. buceras,
and C. viminalis. C. erectus significantly decreases LasA, LasB, and pyoverdin
production, but not biofilm formation, whereas B. buceras affects all but elastase activity.
B. buceras also has a significant effect on the expression of lasI, lasR, rhlI, and rhlR, and
the concentration of OdDHL and BHL. C. erectus exhibits the same pattern of effect on
QS genes and signaling molecules, though to a lesser extent. C. viminalis decreases all
three virulence factors and biofilm formation, all QS genes tested and OdDHL. Research
is currently underway in our lab to isolate active chemicals from these species.
The plant kingdom has long been a source of medicines, and as such, there have
been many ethnobotanically-directed searches for agents to treat infections

(e.g.:

(Camporese et al., 2003; Cowan, 1999; Gnanamani et al., 2003; Hernandez et al., 2003)).
However, most studies focus solely on bactericidal effects. Since the plants in this study
show little, if any, cidal activity (Adonizio et al., 2006), quorum inhibition remains a
potential mode of action. Shifting our focus to anti-QS and anti-virulence may reveal new
quorum quenching compounds from medicinal plants and provide a novel method of
treating infection.
In conclusion, the effects of the studied plant extracts on P. aeruginosa are quite
complicated, and perhaps extend beyond the domain of the QS hypothesis. However, the
reduction of QS gene expression and signaling molecules and the end-effect on virulence
factor production provides some insight into why these plants were used in the past and
how they can be used in the future to combat P. aeruginosa and other bacterial infections.
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4.1 Abstract
Expression of a myriad of virulence factors and innate antibiotic resistance
enables the opportunistic human pathogen Pseudomonas aeruginosa to create intractable
infections. Using a nematode model we efficiently screened for novel inhibitors of this
pathogen. Aqueous extracts of three plants: Conocarpus erectus, Callistemon viminalis,
and Bucida buceras were examined in this study for their effects on P. aeruginosa killing
of the nematode Caenorhabditis elegans. Results were evaluated in both toxin-based and
infection-based assays with P. aeruginosa strains PAO1 and PA14. The tested plant
extracts prevented mortality via gut infection in almost 60% of the worms, and caused a
50-90% reduction in death from toxin production. All extracts inhibited nematode death
by P. aeruginosa without host toxicity, indicating their potential for further development
as anti-infectives.

Keywords: Quorum sensing, medicinal plants, virulence factors, Pseudomonas
aeruginosa, Caenorhabditis elegans, nematode

Abbreviations: QS, Quorum Sensing; AHL, Acyl-Homoserine Lactone; WT, Wild
Type; BHI, Brain-Heart Infusion media; NGM, Nematode Growth Media
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4.2 Introduction
Pseudomonas aeruginosa is one of the leading pathogens among patients
suffering from cystic fibrosis, diffused pan-bronchitis, and chronic obstructive pulmonary
disease (Hoiby, 1994; Lieberman, 2003; Registry, 2005). In addition, it remains one of
the major causes of nosocomial infections (Centers for Disease Control and Prevention,
2004). The success of this organism is attributed to numerous virulence factors (Smith &
Iglewski, 2003a; Tang et al., 1996), its ability to form biofilms (Costerton, 1995) and
innate antibiotic resistance (De Kievit et al., 2001; Fisher et al., 2005).
Current anti-pseudomonal treatment includes elevated doses of beta-lactam,
fluoroquinolone, or aminoglycoside antibiotics (Hauser & Sriram, 2005). However, these
drugs possess a high degree of toxicity, and mucoid strains of P. aeruginosa are rarely
eradicated by these treatments (Hauser & Sriram, 2005; Pederson, 1992). The failure of
existing antibiotics to control infection makes it crucial to find alternatives to currently
available drugs. Since pathogenicity in many bacteria is regulated by quorum sensing
(QS), or cell-to-cell communication, inhibition of this system can cause attenuation of
virulence and protect against infection (Hentzer et al., 2003; Juhas et al., 2005; Smith &
Iglewski, 2003b).
Plants have evolved numerous chemical strategies for deterring pathogen attack,
including the production of bactericidal and anti-infective compounds, leading to their
use as medicines [for a review see (Lewis & Ausubel, 2006)]. In our previous work, we
demonstrated that a number of medicinal plants exhibit anti-QS activity (Adonizio et al.,
2006). Extracts of these plants were later shown to have an effect on virulence factor
production, biofilm formation, QS-gene expression, and autoinducer production in P.

91

aeruginosa (Adonizio et al., 2008b). In this study, we assessed the ability of three plant
extracts to attenuate P. aeruginosa killing of the nematode, Caenorhabditis elegans.
C. elegans is well established as a pertinent and practical model for studying
bacterial virulence (Darby et al., 1999; Tan & Ausubel, 2000), as a number of P.
aeruginosa factors important in the killing of C. elegans are also relevant to mammalian
systems (Rahme et al., 1995; Tan et al., 1999a). “Fast-killing” of C. elegans by P.
aeruginosa strain PA14 (on rich media) is mediated through production of virulence
factors such as phenazines, whereas “slow-killing” (on minimal media) occurs via
ingestion of the bacteria and subsequent infection (Mahajan-Miklos et al., 1999; Tan et
al., 1999a; Tan et al., 1999b). The related strain PAO1 causes death through cyanide
poisoning and neuromuscular paralysis (Gallagher & Manoil, 2001). Importantly, P.
aeruginosa-mediated killing of C. elegans in all three of these cases is dependent in part
on the QS system (previous references). Thus, addition of plant compounds that have an
effect on P. aeruginosa QS, should therefore attenuate virulence factor production and
subsequent death of C. elegans.
The advantage in using a live animal model when screening for anti-infective
compounds is that both efficacy and host toxicity of a plant extract can be tested
concurrently. In this report, we show that extracts from three different plant species
cause a marked decrease in P. aeruginosa killing of C. elegans, without affecting worm
fitness on E. coli. This approach can be expanded to the screening of natural product
libraries or native extract sources.
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4.3 Methods
4.3.1 Preparation of plant extracts
Conocarpus erectus (Combretaceae), Callistemon viminalis (Myrtaceae), and
Bucida buceras (Combretaceae) were collected and processed according to methods
described previously (Adonizio et al., 2006). Briefly, pulverized plant material was
extracted into boiling water, freeze-dried using a lyophilizer, and stored at –20 °C until
needed. Lyophilized extracts were reconstituted in a small volume of sterile water and
added to the molten agar at a final concentration of 1 mg ml-1.

4.3.2 Bacterial strains and growth conditions
Because the tested extracts have been shown to affect the bacterial quorum
sensing (QS) system (Adonizio et al., 2008b; Adonizio et al., 2006) the QS-mutant ΔlasR
was used as a reference strain. P. aeruginosa PAO1 (Holloway & Morgan, 1986) and its
isogenic mutant PAO1ΔlasR (Gambello, 1991) were used in the paralytic assay. PA14
(Rahme et al., 1995) and PA14ΔlasR (Liberati et al., 2006) were used in the slow killing
and fast killing assays. Escherichia coli OP50 was used as the control in all assays as it is
the standard laboratory food of C. elegans (Brenner, 1974). All bacterial strains were
grown overnight in LB broth at 37 °C, and transferred to plates depending on the required
conditions.

4.3.3 Nematode culture
The wild type C. elegans (Bristol) N2 hermaphrodite strain was used in this study
(Brenner, 1974). Worms were synchronized by hypochlorite treatment of gravid adults,
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hatching the eggs overnight in M9 minimum buffer (Brenner, 1974), and plating L1-stage
worms onto lawns of E. coli on nematode growth media (NGM) plates (Brenner, 1974).
Synchronized worms were grown to L4 or young adult stage at 25 °C for use in the
killing assays.

4.3.4 C. elegans paralytic assay (PAO1)
Brain-heart infusion (BHI) agar plates with or without plant extract were seeded
with 10 μl of an overnight culture of OP50, PAO1 or PAO1ΔlasR, and incubated at 37 °C
for 24 hours to form lawns of bacteria (Darby et al., 1999). Nematodes were washed off
stock plates and suspended in a minimal volume of M9 buffer (pH 6.5). Droplets
containing 20-40 adult nematodes were placed onto the P. aeruginosa lawns and the
plates were then incubated at room temperature (21–23 °C). Worms were evaluated for
viability every hour for a total of 4 hours. Worms were scored as dead when they no
longer responded to physical stimuli.

4.3.5 C. elegans fast killing assay (PA14)
Fast killing plates (peptone-glucose medium with 0.15M sorbitol) (MahajanMiklos et al., 1999) with or without plant extract were seeded with 10 μl of an overnight
culture of OP50, PA14 wt, or PA14ΔlasR. Plates were incubated for 24 hours at 37 °C,
then at room temperature (~21-23 °C) for another 12 h. Approximately 20 L4 stage C.
elegans were transferred with a wire pick onto plates at this time. Worms were evaluated
for viability every hour for a total of 4 hours. As in the previous assay, worms were
considered dead when they no longer responded to physical stimuli.
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4.3.6 C. elegans slow killing assay (PA14)
Slow killing plates (modified NGM) (Tan et al., 1999b) with or without plant
extract were seeded with 10 μl of an overnight culture of OP50, PA14 wt, or PA14ΔlasR.
Plates were incubated for 24h at 37 °C, then at room temperature (~21-23 °C) for another
24 h. Approximately 20 L4 stage C. elegans were transferred onto plates at this time.
Worms were evaluated for viability every 2-4 hours for a total of 58 h. As in the
previous assays, worms were considered dead when they no longer responded to physical
stimuli.

4.3.7 Statistics and reproducibility
All experiments were performed in triplicate. Killing curves represent the mean of
three separate experiments. Data were analyzed using one-way analysis of variance
(ANOVA) with a P-value of 0.05 using the statistical software package SPSS (Chicago,
IL). Since the starting number of worms was different in each case, the percent alive
rather than actual number of worms was used for comparison.

4.4 Results and discussion
In this study we assess the potential of extracts from C. erectus, C. viminalis, and
B. buceras to reduce nematode death resulting from P. aeruginosa infection. Prior work
on these plants revealed an effect on the bacterial QS system (Adonizio et al., 2008b;
Adonizio et al., 2006); thus the QS-mutant ΔlasR was used as a reference strain.
Although there is some precedence for testing plant extracts in a nematode model system

95

(Rasmussen et al., 2005), this is the first study to evaluate a statistically significant
number of worms in both toxin and infection-based assays.

Figure 4.1 Nematode killing curves comparing wt, QS mutant, and wt with plant extract.
(A) Paralytic (PAO1), (B) Fast-killing (PA14), and (C) Slow-killing (PA14) assays for C.
elegans. P. aeruginosa wt (black dash), ΔlasR mutant (grey dash), wt + C. viminalis
(black dot), wt + C. erectus (black line), wt + B. buceras (grey line). In all cases, the
addition of plant extract rescued the worms to a level at or above a ΔlasR QS mutant.

4.4.1 Medicinal plants reduce C. elegans paralytic killing by P. aeruginosa
Previous studies have shown that QS signaling is required for maximum levels of
worm killing (Mahajan-Miklos et al., 1999; Tan et al., 1999b). Thus, the success of these
plant extracts against P. aeruginosa strain PAO1 in terms of blocking QS signaling
(Adonizio et al., 2008b) suggests they might also reduce death in a PAO1-nematode
model. Approximately 50% of the worms died between hours 1 and 2 after transfer to
PAO1 with all nematodes dead after 4 hours (Figure 4.1a). In contrast, all of the worms
on E. coli OP50 remained alive throughout the assay. As expected, the QS-mutant
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PAO1ΔlasR showed reduced nematode death with 85% alive between hours 1 and 2 and
74% still alive at 4 hours (Figure 1a). At the 4-hour mark, approximately 85%, 84%, or
87% of the worms were alive on PAO1 wt plates that contained C. erectus, C. viminalis,
or B. buceras extracts, respectively (Figure 4.1a). In this, and all assays in this study,
there was no observable effect of the added plant extracts on worm survival, lifespan, or
brood size on E. coli OP50 (not shown), indicating a lack of toxicity of the compounds
therein.
All three of the plant extracts, when added to plates containing PAO1 wt,
suppressed killing to a level greater than the QS mutant (Figure 4.1a). That is, there was
a significant difference between PAO1ΔlasR and the extract plates (p < 0.05 in all cases),
but not between individual extracts at the end of the assay. All extract plates and the lasR
mutant were significantly different than PAO1 wt without treatment.
Death via PAO1 is due to cyanide asphyxiation and paralysis of C. elegans
(Gallagher & Manoil, 2001).

The hcn operon in P. aeruginosa mediates cyanide

production and is controlled by the QS regulators LasR and RhlR (Pessi & Haas, 2000).
Attenuation of virulence and nematode mortality has been shown with both ΔlasR (Darby
et al., 1999) and Δhcn (Gallagher & Manoil, 2001) strains. Thus, the results from the
paralytic assay suggest that the addition of these extracts are affecting the production of
cyanide either through hcn directly; or indirectly via the QS genes. The latter hypothesis
agrees with our previous in vitro analysis in PAO1 (Adonizio et al., 2008b) which
showed a significant reduction of lasR and rhlR gene activity by these extracts.
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4.4.2 Medicinal plants reduce C. elegans fast killing by P. aeruginosa
The results of the fast killing assay are seen in Figure 4.1b. On PA14 wt,
approximately 50% of the worms were dead within two hours, with all worms dead by 4
hours. At this point, all of the worms on OP50 were still alive. Again, the QS-mutant
(PA14ΔlasR) reduced nematode death, with 75% alive between hours 1 and 2 and 47%
alive at 4 hours. At the end of the assay, approximately 53%, 75%, or 90% of the worms
were alive on PAO1 wt plates with added C. erectus, C. viminalis, or B. buceras extracts
respectively (Figure 4.1b). As with PAO1, all three of the plant extracts suppressed
killing at or above the level of the QS mutant. There was no significant difference
between PA14ΔlasR and the C. erectus extract plates at 4 hours (p > 0.05), however C.
viminalis and B. buceras extracts were significantly better at preventing worm death (p <
0.01 in both cases). Extract-containing plates were all significantly different from each
other and but still showed a large reduction in nematode death when compared to PA14
wt without treatment. Overall there is a pronounced inhibitory effect of the plant extracts
on P. aeruginosa PA14 fast-killing of C. elegans.
Fast-killing of C. elegans is mediated through production of virulence factors
such as phenazines (Mahajan-Miklos et al., 1999). A ΔphnAphnB deletion mutant was
shown to completely abolish nematode death, while a TnphoA mutation of the related
gene phzB was shown to greatly reduce mortality in mice and Arabidopsis (MahajanMiklos et al., 1999). Like many virulence factors, phenazines are under control of the
QS gene rhlR (Brint & Ohman, 1995; Latifi et al., 1995). The results from the PA14 fastkilling assay suggest the addition of extracts affect phenazine production, either through
the phz and phn genes or indirectly through the QS system via rhl.
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All three extracts were shown previously to significantly affect the rhlI/R system;
however, C. erectus has less of an effect on AHL production and biofilm formation
(PAO1) (Adonizio et al., 2008b) than either B. buceras or C. viminalis. Though still
successful, C. erectus was less efficient in preventing nematode death in the fast-killing
assay than the other extracts.

4.4.3 Medicinal plants reduce C. elegans slow killing by P. aeruginosa
The slow killing assay left 50% of nematodes dead on PA14 wt between hours 48
and 50 with all worms dead at 58 hours. (Figure 4.1c). The control worms on E. coli
OP50 were alive throughout the assay. The QS-mutant (PA14ΔlasR) reduced nematode
death, with 75% alive between hours 48 and 50 and 53% alive at 58 hours. At this time,
approximately 60%, 59%, or 57% of worms were alive on PAO1 wt plates with added C.
erectus, C. viminalis, or B. buceras extract respectively (Figure 4.1c). All three of the
plant extracts when added to plates containing PA14 wt suppressed killing to the level of
the QS mutant. There was no significant difference between PA14ΔlasR and the extract
plates or between individual extracts at 58 hours (p > 0.05 in all cases): however, all
extracts were significantly different from PA14 wt without treatment. This suggests a
marked effect of the plant extracts on P. aeruginosa infection of C. elegans.
Slow-killing of C. elegans occurs over approximately 60 hours due to ingestion of
and subsequent infection by P. aeruginosa (Tan et al., 1999). Nematode mortality is
attenuated with TnphoA-mutations of lasR and gacA (Tan et al., 1999b), suggesting QS is
required for the infection process. The addition of plant extracts in this assay drastically
reduces nematode death suggesting an effect on lasR or gacA.
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Previous work on these extracts corroborates the inhibitory effect on lasR,
however the effect on gacA was not directly tested (Adonizio et al., 2008b). An effect on
either of these factors remains a plausible hypothesis.

4.5 Conclusions
All three extracts in all three assays showed a highly significant reduction of
virulence when compared to PAO1 and PA14 wt without treatment. Overall, the tested
plant extracts reduced nematode death approximately 60-90 percent by P. aeruginosa wt.
In each case, this reduction was equal to or greater than that of the corresponding QS
mutant strain. The fact that the plant extracts reduce virulence across the board, suggests
that they are most likely affecting an upstream QS gene such as las or rhl, or perhaps a
global regulator such as gacA. This further corroborates our previous data on the anti-QS
effect of these plant extracts (Adonizio et al., 2008b). All extracts inhibit nematode death
without significant bactericidal effect, leaving QS inhibition as a plausible hypothesis. In
addition, none of the tested plants showed any toxicity in the nematode model, making
them reasonable candidates for purification and drug development.
C. erectus, B. buceras, and C. viminalis (and closely related species) have been
used medicinally to treat bacterial infection either as teas or poultices (Burkhill, 1985;
Irvine, 1961; Melendez, 1982; Morton, 1981; Stewart & Percival, 1997). Thus, the plants
were extracted with hot water to provide greater congruity with traditional preparation
methods. Although teas and poultices are many steps removed from modern formulae,
traditional use suggests the potential success of topical or enteral routes of administration.
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With the increase in bacterial resistance to antibiotics, we might look to the past
in hopes of finding solutions for the future. Plants have been used medicinally for
thousands of years, and even without marked antibiotic activity, these three plants are
still efficacious in ameliorating disease. We have previously shown the activity of these
plants on P. aeruginosa alone, and although the exact mechanism of action is not yet
known, the nematode experiments described in this paper are consistent with their
previous and potential further use as anti-infectives.
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Pseudomonas aeruginosa”
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5.1 Abstract
Two stereoisomeric ellagitannins, vescalagin and castalagin were isolated from an
aqueous extract of Conocarpus erectus L. (Combretaceae). Structures were confirmed via
mass spectrometry and NMR spectroscopy. Both ellagitannins were shown to decrease
AHL production, quorum sensing (QS) gene expression, and virulence factor production
in Pseudomonas aeruginosa. This is the first report of these compounds being isolated
from this species, and also the first report of their activity on the QS system of P.
aeruginosa.

Keyword Index
Conocarpus erectus; Combretaceae; quorum sensing inhibition; ellagitannins; castalagin;
vescalagin

Abbreviations: QS, Quorum Sensing; AHL, Acyl-Homoserine Lactone; OdDHL, N-(3oxododecanoyl)-L-homoserine lactone; BHL, N-butanoyl-L-homoserine lactone; TLC,
Thin Layer Chromatography; HPLC, High Pressure Liquid Chromatography; NMR,
Nuclear Magnetic Resonance
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5.2 Introduction
Overuse of antibiotics has led to widespread resistance in pathogenic bacteria
including the model organism Pseudomonas aeruginosa. This ubiquitous Gram-negative
pathogen is a frequent cause of morbidity and mortality in cystic fibrosis patients
(Registry, 2005), and nosocomial infections in burn victims, and immunocompromised
individuals (Centers for Disease Control and Prevention, 2004). P. aeruginosa and many
other organisms are now highly resistant to current antibiotic treatment exposing the need
for alternative methods of inhibition.
In our previous work (Adonizio et al., 2008a; Adonizio et al., 2008b; Adonizio et
al., 2006), we have shown a number of medicinal plants, including Conocarpus erectus,
to be effective in inhibiting pathogenicity of P. aeruginosa via attenuation of the quorum
sensing (QS) system (for a review of QS see (Fuqua & Greenberg, 1998)). Addition of C.
erectus to culture media affected a significant reduction of QS gene expression and
virulence factor production in P. aeruginosa (Adonizio et al., 2008b). It also prevented
60-90% of nematode death from this organism in three different killing assays (Adonizio
et al., 2008a).
Commonly known as buttonwood, C. erectus has been used throughout the
Caribbean, Puerto Rico, and parts of Africa against catarrh, conjunctivitis, diarrhea,
syphilis,

and

gonorrhea

(Burkhill,

1985;

Irvine,

1961;

Melendez,

1982).

The activity of this plant on the bacterial QS system may explain its traditional use for
these diseases. This work reveals two hydrolyzable tannins, vescalagin and castalagin, to
be responsible for anti-QS activity in C. erectus.
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Tannins are widespread throughout the angiosperms (Okuda et al., 1993),
conferring structural benefits to the plant while providing protection through antioxidant
and antifeedant activity (Forkner et al., 2004; Hagerman et al., 1998). Often classified as
‘waste’ in natural products chemistry due to their abundance and lack of protein
specificity (Zhu et al., 1997), tannins and other polyphenolics have been previously
ignored by the pharmaceutical industry. However, recent studies on the health benefits of
these types of compounds are creating a resurgence of interest from the medical field
(Ferreira et al., 2005; Haslam, 1996; Okuda, 2005; Quideau et al., 2005).
Castalagin and vescalagin were first characterized by Mayer et al (Mayer et al.,
1967; Mayer et al., 1970) and belong to a sub-class of hydrolyzable tannins known as Cglycosidic ellagitannins derived from gallic acid metabolism (Quideau & Feldman,
1996). They are highly water-soluble compounds featuring an open-chain glucose core
esterified to numerous oxidatively coupled galloyl moieties (specifically a 4,6hexahydroxybiphenoyl (HHBP) unit and a 2,3,5-nonahydroxyterphenoyl (NHTP) unit)
(Khanbabaee & van Ree, 2001). These complex structural units confer stereochemical
rigidity to the molecule, and in fact, C-glycosidic ellagitannins would seem to have a
higher tendency for selective protein interaction than other classes of polyphenolics
(Haslam, 1996; Zhu et al., 1997).
Many polyphenolics possess antimicrobial activity potentially explained by
inhibition of microbial enzymes, substrate or iron deprivation, or inhibition of oxidative
phosphorylation (Scalbert, 1991). However, the same study shows most bacteria are not
susceptible to ellagitannins, i.e. these compounds do not seem to have growth inhibition
or cidal effects. Furthermore, it has been shown that ellagic acid (a component of
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ellagitannins) can interfere with bacterial quorum sensing (Huber et al., 2004). This,
combined with our previous work on the anti-QS activity of C. erectus leads to the
hypothesis that ellagitannins may function as inhibitors of the bacterial quorum sensing
(QS) system.

5.3 Materials and methods
5.3.1 Isolation and verification of active compounds
5.3.1.1 Plant extraction
Leaves of Conocarpus erectus (Combretaceae), were collected and processed
according to methods described previously (Adonizio et al., 2006). Briefly, pulverized
plant material was extracted into boiling water, freeze-dried using a lyophilizer, and
stored at -20 °C until needed.

5.3.1.2 Bioassay-guided fractionation
Anti-QS activity was confirmed in the crude extract (Adonizio et al., 2006) and
followed throughout the separation process using the P. aeruginosa PAO1-derived
biomonitor strains pPCS1001 and pPCS1002 (Pesci et al., 1997). These strains harbor
lacZ fusions to the QS gene promoter regions enabling blue/white selection for QS
activity. Bioassays were carried out as previously described (Adonizio et al., 2006) with
some modification. Briefly, LB agar plates were seeded with a lawn of one of the
biomonitor strains and allowed to dry for 1 hour. Small wells were then cut and aspirated
from the agar, and 10 μl aliquots of each fraction were pipetted into each well. Wells
were checked at 18h and 24h for zones of QS inhibition.
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5.3.1.3 Preliminary thin layer chromatography
Approximately 1 μl of crude extract was spotted to reverse phase thin layer
chromatography (TLC) plates (two spots run in tandem). Adequate separation for
visualization of three distinct bands from each spot was achieved with an 80:20
ACN/H2O mobile phase containing 0.1% formic acid (Figure 5.1a). A 1% ferric chloride
stain was applied to one-half of the plate as a phenolic indicator (Figure 5.1b). The other
side was overlaid with agar containing one of the aforementioned PAO1 biomonitor
strains to indicate anti-QS activity (Figure 5.1c).

5.3.1.4 Fractionation methods
The fractionation of crude aqueous extract prior to HPLC separation is illustrated
in Figure 5.2. Separation was patterned after methods developed for wine polyphenolics
(Sun et al., 2006). A C18 PrepSep column (Fisher Scientific 11-131-11 5 g / 20 ml) was
conditioned with 200 ml methanol followed by 200 ml water at pH 7. The flow rate of
approximately 2 ml/min was controlled through positive pressure applied via syringe.
The crude aqueous extract of C. erectus (0.25g) was resuspended in 5 ml water, adjusted
to pH 7 with sodium hydroxide, and added to the column. Fraction A was eluted with
approximately 150 ml water at pH 7. The column was then washed with 100 ml water
and dried under vacuum for several seconds. Fraction B was then eluted with
approximately 400 ml ethyl acetate. The column was washed with ethyl acetate and
dried under vacuum before elution of fraction C with 200 ml of acidified methanol. The
presence of phenolics in each fraction was monitored by periodically spotting to TLC
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plates coated with ferric chloride reagent. Each fraction was evaporated to dryness
before bioassay at 1 mg/ml concentration.

5.3.1.5 HPLC separation
Fraction A was separated on an Agilent 1200 series LC system (Agilent
Technologies, USA) using an Altima C18 column (5μ, 10 x 250 mm; 100μL injection
volume). A water-acetonitrile mobile phase with 0.1% formic acid was used with a
flowrate of 1.5 ml/min. Conditions were as follows: 0-2 min, 0% acetonitrile; 2-47 min,
0-40% acetonitrile; 47-48 min, 40-100% acetonitrile; 48-50 min, 100% acetonitrile; 5051 min, 100-0% acetonitrile. Fractions were collected manually based on absorbance at
313 nm and tested for anti-QS activity.

5.3.1.6 Mass spectrometric analysis
Direct injection electrospray ionization mass spectroscopy and MS-MS analysis
(Esquire 3000+, Ion Trap Mass Spectrometer Bruker Daltonics, Germany) were used for
mass identification of vescalagin and castalagin. The isolated peaks 3 and 4 (Figure 5.4)
were injected directly into the ESI source with a syringe pump at a flow rate of 0.2
ml/min. Nebulizer gas was maintained at 7 psi. Capillary temperature was set at 300°C
with a voltage of 3.5 kV. Spectra were obtained in negative ion mode with a scanning
range of 100-1000 m/z. MS-MS of compounds were also acquired in negative ion mode.
Howevr, the conditions were modified by increasing capillary temperature and voltage to
325 °C and 4 kV respectively. Trap rolling and smart fragmentation settings were
activated, and the instrument was set to scan from 50-1000 m/z. Exact mass
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measurements were made with a Waters Q-Tof2 using reserpine as a lock mass. Samples
were introduced via LC flow and reserpine flow from a syringe pump was T-ed in.
Spectra were obtained in the positive ion mode with a scanning range from 100-1000
m/z.

5.3.1.7 NMR spectroscopy
NMR spectra were recorded using a Varian Inova 600 MHz FT-NMR
spectrometer with D2O acidified with d-TFA or D2O:[D6]-acetone (8:2) as solvents.
Proton spectra were obtained using standard parameters. The structure was elucidated
using COSY, HMQC, and HMBC, and through comparison with the standard spectra of
vescalagin and castalagin.

5.3.2 Biological assays
Assays for AHL production, QS gene activity, and virulence factor production
(LasA, LasB, and pyoverdin) were carried out as detailed in our previous work (Adonizio
et al., 2008b). Samples were tested at the following concentrations: 1mg/ml crude extract
of C. erectus, 40 μg/ml crude extract, 40 μg/ml vescalagin, or castalagin.

These

additions were compared to a media-only control for the reduction of QS. Prototypic P.
aeruginosa strain PAO1 (Holloway & Morgan, 1986), and its promoter-fusion
derivatives PlasR-lacZ (pPCS1001), and PrhlR-lacZ (pPCS1002), (Adonizio et al., 2008b;
Pesci et al., 1997) were used throughout this study. In addition, Staphylococcus aureus
(ATCC # 12600) was used in the LasA staphylolytic assay.

109

5.3.3 Statistical analysis
All experiments were performed in triplicate. Data were analyzed using one-way
analysis of variance (ANOVA) with a P-value of 0.05 using the statistical software
package SPSS (Chicago, IL).

5.4 Results and discussion
This report details the isolation and verification of two C-glycosidic ellagitannins,
castalagin and vescalagin, from C. erectus and the confirmation of anti-QS activity of
these compounds. The isolation procedure was largely directed by anti-QS bioassays
using P. aeruginosa strains containing a lacZ fusion to the QS gene lasR or rhlR
(Adonizio et al., 2008b; Pesci et al., 1997). Each fraction was pipetted into a small well
in an agar plate seeded with one of these biomonitor strains and the appropriate reagents
for visualization of lacZ activity. Active fractions resulted in a change of color in the
biomonitor strain from blue to off-white in the area surrounding the well indicating antiQS activity. Only fractions with activity were subjected to further separation.

5.4.1 Isolation and verification of active compounds
5.4.1.1 TLC reveals a phenolic compound responsible for anti-QS activity
Prior to column chromatography, separation was attempted with various mobile
phases on thin layer chromatography (TLC) plates. Reverse phase TLC of crude extract
of C. erectus using an acidified acetonitrile/water mobile phase revealed two long-wave
UV-reactive bands and one chromatic band, the latter being brown in color and slightly
tailing (Figure 5.1a).
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Figure 5.1

Thin layer chromatography (TLC) of C. erectus crude extract and the

visualization of phenolic anti-QS activity. (a) Two long-wave UV-reactive bands (circled
in pencil) and one chromatic band are visible after running with an acidified 80:20
ACN/H2O mobile phase (RP-C18 silica plates). (b) Phenolic compounds are indicated by
a blue spot after reaction with ferric chloride stain. (c) Overlay of the TLC plate with
agar containing PAO1 derived biomonitor strain pPCS1001 (PlasR-lacZ ) indicates antiQS activity (loss of blue color) correlating with phenolic band.

The plates were reacted with a number of different agents, the most notable being
ferric chloride, a stain for phenolic compounds. Ferric chloride staining resulted in the
chromatic band turning dark blue, indicating phenolic compounds in this region (Figure
5.1b). An unstained portion of the TLC plate was overlaid with agar containing an antiQS biomonitor strain derived from P. aeruginosa (PlasR-lacZ (pPCS1001)) (Adonizio et
al., 2008b; Pesci et al., 1997). Anti-QS activity was visualized as a loss of blue color over
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the phenolic band due to reduced lasR expression and linked β-galactosidase activity
(Figure 5.1c).
Anti-QS activity against the tested lasR biomonitor strain correlates with our
previous data on the reduction of lasR gene expression seen with the crude extract of C.
erectus (Adonizio et al., 2008b). The localization of this activity indicates phenolic
compounds are responsible for the anti-QS activity seen in this species.

Phenolic

compounds have been previously shown to interfere with bacterial QS (Huber et al.,
2004).

5.4.1.2 Fractionation of polyphenolics in crude extract
Since the TLC staining and overlay procedure revealed the phenolic band to
contain the anti-QS activity in C. erectus, larger-scale fractionation was then tailored to
separation of these compounds. We adopted a method based on the resolution of wine
polyphenols (Sun et al., 2006) . A schematic of fractionation can be seen in Figure 5.2.
Crude aqueous extract of C. erectus was separated into three fractions based on
solvent polarity. Fraction A eluted with water as a bright yellow liquid believed to
contain phenolic acids and hydrolyzable tannins according to prior work on polyphenolic
separation (Oszmianski et al., 1988; Sun et al., 2006). Fraction B, which eluted with ethyl
acetate, was colorless to pale yellow and likely contained colorless proanthocyanins,
flavanols, and some monomer and oligomer phenolic acids (He et al., 2006; Oszmianski
et al., 1988; Sun et al., 2006). Fraction C, which eluted with acidified methanol, was dark
brown indicating the presence of complex tannins, pigmented proanthocyanidins, and
pyranoanthocyanins (He et al., 2006; Oszmianski et al., 1988; Sun et al., 2006). The
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presence of phenolics in each fraction was monitored by periodically spotting to TLC
plates coated with ferric chloride reagent. Each fraction was tested for anti-QS effect
revealing Fraction A to contain the majority of activity (Figure 5.3, (Panel I)).

Crude Extract (pH 7)

Sep-pak C-18 (pH 7)
Water (pH 7)

A

Bioassay

HPLC
Separation

Ethyl Acetate

B

Bioassay

C

Bioassay

Peak 1

Bioassay

Peak 2

Bioassay

Peak 3

Bioassay

Peak 4

Bioassay

Peak 5

Bioassay

Peak 6

Bioassay

Methanol (pH 2)

Figure 5.2 Schematic of fractionation of C. erectus crude extract. The crude extract and
all fractions were tested for anti-QS activity on PAO1-derived biomonitor strains
pPCS1001 (ΔlasR) and pPCS1002 (ΔrhlR) (Adonizio et al., 2008b; Pesci et al., 1997).
Anti-QS activity is indicated by grey blocks.

113

Panel I

Panel II

Figure 5.3 Anti-QS bioassay of fractionation products of C. erectus. Anti-QS activity
was monitored using PAO1-derived biomonitor strain pPCS1001 (ΔlasR) (Adonizio et
al., 2008b; Pesci et al., 1997). Lighter color indicates anti-QS activity. Fractions A, B,
and C were separated by preparatory chromatography (Panel I). Subsequent fractions 1-6
of initial fraction A were separated via HPLC (Panel II).

Fraction A is the most polar fraction and thus contains phenolic acids and
hydrolyzable tannins. Prior work on ellagic acid and EGCG (a hydrolyzable tannin)
indicated that these compounds outperformed complex tannins (such as those found in
Fraction C) in the inhibition of QS (Huber et al., 2004).

5.4.1.3 HPLC separation reveals two fractions with anti-QS activity
The separation of fraction A via HPLC resulted in six major peaks designated 1 to
6, and a number of minor peaks (Figure 5.4). The detection wavelength was set at 313
nm based on work by Oszmianski et al (Oszmianski et al., 1988). Fractions 1 through 6
eluted at approximately 24, 26.8, 29, 31.7, 33.8, and 36.4 minutes, respectively. Each
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fraction was collected and tested with the anti-QS biomonitor strains revealing activity in
Fractions 3 and 4 (Figure 5.3, (Panel II)).

Figure 5.4 HPLC separation of Fraction A. Optimal separation was achieved using an
Altima C18 column (5μ, 10 x 250 mm; 100μL injection volume) with an acidified wateracetonitrile mobile phase. Absorbance was monitored at a wavelength of 313 nm.
Fractions 1-6 represent pure compounds and were subsequently tested for anti-QS
activity.

5.4.1.4 Vescalagin and castalagin elucidated as active compounds
Fractions 3 and 4 were checked for purity by TLC and behaved as pure
compounds (single, non-tailing bands). Both Fractions 3 and 4 when subjected to mass
spectrometric analysis produced a strong peak at m/z 933 [M-H]- and a smaller fragment
peak at m/2z 466 [M-H]2-.
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MS-MS of compounds 3 and 4 revealed strong peaks at m/z 915 and 613. The
former being simply the parent compound minus water, and the latter indicating the loss
of ellagic acid (302 daltons), a fragment regarded as diagnostic of ellagitannins (Tang &
Hancock, 1995).

A literature review suggested that these compounds may be the

ellagitannins vescalagin and castalagin (Mayer et al., 1967; Mayer et al., 1970; Okuda et
al., 1993; Tang & Hancock, 1995) as they both have a mw of 934 and contain ellagic acid
components. Exact mass measurements revealed a mass of 935.0811 [M+1] for Fraction
3 and 935.0794 for Fraction 4 [M+1], a difference of 2.8 and 1.0 ppm, respectively. The
calculated exact mass for the [M+1] ion of both vescalagin and castalagin is: 935.0785
for C41H27O26+.

Figure 5.5 Structures of the stereoisomeric ellagitannins castalagin and vescalagin.
(Image: (Zhentian et al., 1999))
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NMR data (supplementary data, appendix) were compared with spectra from the
known compounds (Glabasnia & Hofmann, 2006; Tang & Hancock, 1995), thus
confirming the identity of Fractions 3 and 4 as vescalagin and castalagin, respectively
(Figure 5.5). To avoid confusion, these fractions will hereafter be referred to by their
compound names.

5.4.2 Bioassays on P. aeruginosa confirm anti-QS activity of ellagintannins
The anti-QS activity of the ellagitannins vescalagin and castalagin is corroborated
by prior work on the QS-inhibiting properties of ellagic acid (Huber et al., 2004).
However, specific bioassays were necessary to elaborate the precise effect on P.
aeruginosa QS and virulence. Here, we compare the effect of the purified compounds to
that of the crude extract of C. erectus examined in our previous works (Adonizio et al.,
2008a).
Polyphenolics have been shown to act as QS-inhibitors at a concentration range of
20-60 μg/ml (Huber et al., 2004) thus a 40 μg/ml concentration was chosen for the
purified ellagitannins. For comparison, we tested 40 mg/ml and 1 μg/ml concentrations
of crude extract, the latter being the working concentration for our previous studies on of
C. erectus (Adonizio et al., 2008a; Adonizio et al., 2008b).

5.4.2.1 LasA protease activity is reduced in the presence of ellagitannins
LasA belongs to the β-lytic endopeptidase class of proteases (Kessler, 1995) and
plays a major role in host tissue degradation (Kharazmi, 1989; Morihara & Homma,
1985).

LasA protease activity was determined by measuring the ability of culture
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supernatants to lyse boiled S. aureus cells (Kong et al., 2005). There was a significant
decrease in LasA activity compared to that of the control when strain PAO1 was grown
in the presence of C. erectus crude extract at 1 mg/ml (91% decrease), and a lesser effect
at 40 μg/ml (26% decrease) (Table 5.1). Purified vescalagin and castalagin affected
significant reductions in LasA activity as well, with decreases of 73% and 80%,
respectively (Table 5.1). The significant effect on LasA protease production is in
agreement with our previous data on C. erectus (Adonizio et al., 2008b), and suggests
that vescalagin and castalagin are responsible for the reduction in LasA activity.

5.4.2.2 LasB elastase activity is reduced in the presence of ellagitannins
LasB elastase is a zinc metalloprotease capable of affecting the host immune
system and destroying biological tissue (Bever & Iglewski, 1988). The elastolytic activity
of culture supernatants was determined using elastin Congo red (ECR; Sigma, St. Louis,
MO) (Ohman et al., 1980). There was a significant decrease in LasB activity compared to
that of the control when PAO1 was grown in the presence of C. erectus at 1 mg/ml (70%
decrease) or 40 μg/ml (60% decrease) (Table 5.1). Purified vescalagin and castalagin also
affected significant reductions in LasB activity, with decreases of 67% and 63%,
respectively (Table 5.1). The effect on LasB production agrees with our previous data
(Adonizio et al., 2008b) on C. erectus, and suggests vescalagin and castalagin are
responsible for the reduction in LasB activity.
Previous studies by Huber et. al. indicate a 40% decrease in lasB activity when
the related organism Pseudomonas putida is grown in the presence of 30 μg/ml ellagic
acid (a component of ellagitannins) (Huber et al., 2004).
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Table 5.1 Effect of crude extract of C. erectus and purified ellagitannins on P. aeruginosa
virulence factors
Culture conditions LasA activitya Elastase activityb Pyoverdin productionc
Media only

0.243 ± 0.024

142.7 ± 17.7

4710 ± 238

Crude 1 mg/ml

0.021 ± 0.004*

42.9 ± 2.1*

700 ± 212*

Crude 40 μg/ml

0.179 ± 0.013*

56.7 ± 5.5*

4208 ± 205

Vescalagin

0.066 ± 0.008*

47.2 ± 6.8*

4226 ± 138

Castalagin

0.048 ± 0.003*

52.7 ± 9.0*

4207 ± 150

a

LasA activity was expressed as reduction in OD600 per hour per microgram total protein

b

Elastase activity was expressed as absorbance at OD495 per microgram of protein * 1000

c

Pyoverdin production expressed as fluorescence (405/465 nm) per microgram protein

*Significantly different from the “Media only” control at p=0.05

5.4.2.3 Ellagitannins do not affect pyoverdin production
Pyoverdins function as siderophores essentially starving host tissues by
competing with mammalian transferrin for iron (Meyer et al., 1996). They also promote
pathogenicity by stimulating bacterial growth (Cox & Adams, 1985), while autoregulating themselves and the production of other toxins (Beare et al., 2003; Lamont et
al., 2002). Relative concentration of pyoverdin was based on fluorescence of the
supernatant at an excitation wavelength of 405 nm and an emission wavelength of 465
nm (Gemini EM microplate reader). None of the experimental conditions significantly
affected pyoverdin production, with the exception of C. erectus at a concentration of 1
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mg/ml (85% reduction) (Table 5.1).

This is consistent with our previous data on C.

erectus (Adonizio et al., 2008b).
The inability of the purified compounds to reduce pyoverdin levels suggests that
the crude extract contains some factor other than the ellagitannins that is responsible for
this effect. No significant reduction occurred with a crude extract concentration of 40
μg/ml, indicating a relatively high amount of this unknown factor is needed for an effect
on pyoverdin levels.

5.4.2.4 Ellagitannins affect the production of QS signaling molecules
P. aeruginosa manufactures two main quorum sensing signaling molecules N-(3oxododecanoyl)-L-homoserine lactone (OdDHL) and N-butanoyl-L-homoserine lactone
(BHL) called autoinducers (Pearson et al., 1994; Pearson et al., 1995). These molecules
diffuse into the environment, and when they reach a putative threshold concentration,
they activate the QS receptor genes. Inhibition of these signals has been shown to cause
attenuation of pathogenicity (Adonizio et al., 2008a; Adonizio et al., 2008b; Manefield et
al., 1999; Whitehead et al., 2001b).
No significant decreases in OdDHL levels were seen with either the crude extract
or the purified compounds (Table 5.2), the former being consistent with our previously
acquired data (Adonizio et al., 2008b). BHL levels however, were affected by the crude
extract at a concentration of 1 mg/ml (20% reduction) and purified vescalagin (21%
reduction). This is consistent with our previous work on C. erectus which revealed a
25% decrease in BHL levels, suggesting that vescalagin is responsible for this reduction.

120

Table 5.2 Effect of ellagitannins on P. aeruginosa QS genes and AHL production
AHL Productiona

Gene Expressionb

Culture conditions
C12-AHL

a
b

C4-AHL

lasI

lasR

rhlI

3873 ± 260

4823 ± 385

4933 ± 333

rhlR

Media only

1.328 ± 0.14 0.621 ± 0.03

Crude 1 mg/ml

1.082 ± 0.07 0.496 ± 0.05* 3065 ± 247* 1325 ± 275* 3383 ± 111* 4535 ± 231*

Crude 40 μg/ml

1.431 ± 0.06 0.578 ± 0.08

3367 ± 276

2873 ± 188* 3187 ± 249* 4667 ± 194*

Vescalagin

1.227 ± 0.16 0.489 ± 0.01* 2049 ± 93*

1703 ± 297* 3514 ± 306* 4129 ± 287*

Castalagin

1.389 ± 0.20 0.703 ± 0.01

2465 ± 116* 2160 ± 509* 4542 ± 199

7639 ± 216

4904 ± 348*

AHL production was expressed in µM
Gene expression was measured via β-galactosidase activity of the lacZ gene fusion

products and expressed as Miller Units
* Indicates significance at p=0.05

5.4.2.5 Ellagitannins affect QS gene expression
P. aeruginosa elaborates two main sets of QS systems: lasI-lasR and rhlI-rhlR
(Schuster & Greenberg, 2006). LasI and RhlI are synthetases that manufacture the
autoinducer signaling molecules mentioned in the previous section. The receptors, lasR
and rhlR, are activated by these signals and, in turn, coordinate the regulation of
pathogenicity.
We tested the effect of castalagin and vescalagin on the transcriptional activity of
the QS-gene promoters using PAO1-derived strains harboring promoter-lacZ fusions (as
described in (Kong et al., 2005) and (Adonizio et al., 2008b). Assays for β-galactosidase
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(lacZ)

activity

in

P.

aeruginosa

were

performed

with

o-nitrophenyl-β-D-

galactopyranoside, as described previously (Mathee et al., 1997).
Significant effects were seen on the activity of all tested QS genes with C. erectus
at 1 mg/ml (Table 2) which agrees with previous results on this species (Adonizio et al.,
2008b). Crude extract at 40 μg/ml reduced the expression of all QS genes to a lesser
extent, leaving lasI marginally insignificant. Castalagin reduced all QS gene levels save
for rhlI which may correspond to the lack of effect on its signaling molecule OdDHL
(Table 1). Vescalagin on the other hand reduced all QS gene levels including rhlI to a
greater extent than castalagin. The significant reduction of rhlI by vescalagin may
correspond to its effect on BHL.
Interestingly, reduction of lasI is more pronounced with the addition of pure
compounds than with the crude extract (Table 2). This may suggest another compound in
the crude extract causing up-regulation of lasI or simply blocking its repression by the
ellagitannins thus balancing out the effect.

5.4.2.6 Ellagitannins do not affect bacterial growth
To confirm that the reduction in virulence was due to QS inhibition and not static
or cidal effects, cell proliferation was monitored using growth curve studies and the
Bradford assay (Bradford, 1976). No significant differences in growth of PAO1 were
seen with either concentration of crude extract or the purified compounds. In comparison,
previous work on ellagic acid shows no effect on growth of the related species P. putida
at concentrations up to 30 μg/ml (Huber et al., 2004).
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5.5 Concluding remarks
Previous research on C. erectus (Adonizio et al., 2008a; Adonizio et al., 2008b)
indicates a marked reduction of QS and inhibition of P. aeruginosa virulence. The
activity of the isolated compounds vescalagin and castalagin are shown here to account
for the majority of the activity in this plant, suggesting a new mode of action for
ellagitannins. Purified ellagitannins affected AHL levels, and QS-gene expression
similarly to the parent extract. Protease and elastase levels were also markedly reduced,
however, pyoverdin was not affected. This may suggest that additional compounds within
C. erectus are responsible for the entire anti-QS effect or that the regulation of pyoverdin
extends beyond the QS system. The latter hypothesis is supported by previous research
on the nature of pyoverdin (Beare et al., 2003; Lamont et al., 2002) and the mixed results
of halogenated furanones on its production (Hentzer et al., 2003; Sakar et al., 2005).
Unlike the furanones, which inhibit QS through competitive AHL inhibition,
ellagitannins are unlikely candidates for signal mimicry based on their size and structure.
The reduction of rhlI expression and BHL levels by vescalagin (Table 2) may suggest a
more direct effect on the rhl QS system, however further studies are necessary to confirm
this activity.
In several cases (Table 1 and 2), differences in the degree of anti-QS activity
between the crude extract and the purified compounds can be explained by a dosage
effect. The extraction of vescalagin and castalagin from the crude extract was found to be
roughly 6% in both cases with our particular methods. Thus, the working concentration
of ellagitannins is as follows: 60 μg/ml in the 1 mg/ml crude extract and 2.4 μg/ml in the
40 μg/ml crude extract.

The tested concentration of the purified compounds falls
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between these two as does the activity in most cases. This pattern is not absolute
however, since unknown compounds in the crude extract may moderate activity.
Castalagin and vescalagin have not been previously isolated from Conocarpus
erectus, and although they may be part of a larger C-glycosidic ellagitannin oligomer, it
is likely these compounds exist in their native state as well. Although tannins are
widespread throughout the plant kingdom, NHTP-bearing ellagitannins such as castalagin
and vescalagin are mostly limited to the Combretaceae, Fagaceae, Melastomataceae, and
Myrtaceae (Okuda et al., 2000). Interestingly, the plant species found in our previous
work to have the highest levels of anti-QS activity are within these four families
Conocarpus erectus L. (Combretaceae), Callistemon viminalis (Sol.ex Gaertn.) G. Don
(Myrtaceae), Bucida burceras L. (Combretaceae), Tetrazygia bicolor (Mill.) Cogn.
(Melastomataceae), and Quercus virginiana Mill. (Fagaceae). (Adonizio et al., 2008b).
This would suggest that similar ellagitannins may be responsible for QS inhibition in
these plants.

5.6 Acknowledgments
We gratefully acknowledge the support of the National Institute of General
Medical Sciences - Research Initiative for Scientific Enhancement (NIGMS-RISE)
program #R25 GM61347 (A.A.), the Cystic Fibrosis Foundation Traineeship Grant
#ADONIZ06H0 (A.A.), and the National Institute of Health, National Center for
Alternative and Complementary Medicine NRSA #1-T32-AT01060-01 (A.A., and K.M.)
and 1-R15-AT002626-01 (K.M.), and NIAID grants R01 AI072508 and R01 AI064332
(F.M.A.) Special thanks go out to Monica Pupo and members of the Clardy lab for NMR

124

interpretation, and Hanna Milewicz, Tomo Kawate, and Steven Casper for
chromatography advice. We would also like to thank the reviewers for their critical
reading of this manuscript and their invaluable suggestions and comments

125

Chapter 6

General Discussion and Summary
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6.1 Overview
With the advent of antibacterial therapy in the 1940s came the consequent
problem of bacterial resistance (Abraham et al., 1941). Early β-lactam antibiotics such as
penicillin quickly lost efficacy, and by the 1960s new drugs were being developed to
replace the old (Fairbrother & Taylor, 1961). Soon, they too would become obsolete, and
so began the Sisyphean task of keeping pathogens at bay.
The search for novel antibiotics is becoming increasingly necessary, though
perhaps more important is the search for novel modes of action against pathogens. A
compound that does not kill an organism, but rather attenuates its virulence could allow
the host immune system to more efficiently clear out an infection. In addition, this type of
action against bacteria is less likely to provide the selective pressure to drive resistance
(Hentzer & Givskov, 2003b). Anti-QS agents seem to fit this niche, but are limited in
number and structural diversity.
This dissertation has served not only to direct research toward ethnobotanical
sources of anti-QS activity (Chapter 2; (Adonizio et al., 2006)), but has confirmed the
hypothesis that anti-QS compounds from medicinal plants can attenuate P. aeruginosa
virulence. A number of plants were shown to reduce the production of virulence factors,
biofilm formation, and QS activity in this intractable, opportunistic pathogen (Chapter 3;
(Adonizio et al., 2008b)). Furthermore, three of these plants were able to prevent P.
aeruginosa infection and toxicity in a live animal model (Chapter 4; (Adonizio et al.,
2008a)). The ellagitannins vescalagin and castalagin were found to be responsible for the
majority of anti-QS activity in the medicinal plant C. erectus (Chapter 5) revealing a
class of compounds not previously tagged with this effect.
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6.2 Anti-QS activity of medicinal plants
The plant kingdom has long been a source of medicines, and the relatively
untapped botanical arena of southern Florida seemed a likely reservoir for anti-QS
compounds. The ability of higher organisms to produce QS inhibitors was first
demonstrated in the marine algae Delisea pulchra (Manefield et al., 1999), and anti-QS
activity has since been found in a number of higher plants (Teplitski et al., 2000).
However, the screening of medicinal plants for this activity has not been explored prior to
this study, and this research sought to forge a new path in the field of medical
ethnobotany.
Fifty medicinal plants of southern Florida were screened for their anti-QS
potential against Chromobacterium violaceum and Agrobacterium tumefaciens (NTL4)
biomonitor strains in a standard disc-diffusion assay (Chapter 2; (Adonizio et al., 2006)).
These biomonitor strains provided a colorimetric assessment of QS inhibition seen as a
zone of pigment loss surrounding the test disc (Chapter 2, Figure 2.2).
Although the biomonitor strains rarely cause disease in humans, they remain
medically relevant due to the similarity of Gram negative QS systems (Whitehead et al.,
2001a). It can be extrapolated that a plant effective against the QS systems of these
species may have activity against disease-causing organisms as well thus validating the
medicinal use of these plants.
Of the tested plants, six showed QS inhibition: Conocarpus erectus
(Combretaceae), Chamaecyce hypericifolia (Euphorbiaceae), Callistemon viminalis
(Myrtaceae), Bucida burceras (Combretaceae), Tetrazygia bicolor (Melastomataceae),
and Quercus virginiana (Fagaceae).
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C. erectus and B. buceras both belong to the family Combretaceae. Leaves from
these tree species have been used medicinally to treat fevers, respiratory ailments,
diarrhea and sexually transmitted diseases throughout the native range of these plants
(Burkhill, 1985; Irvine, 1961; Melendez, 1982; Morton, 1981; Nellis, 1994).
C. viminalis, of the family Myrtaceae, is now considered to be in the genus
Melaleuca. This group includes the “tea trees” (Chapter 1.2.1), which have long been
used to treat skin and respiratory conditions (Duke, 1985; Halcon & Milkus, 2004;
Hammer et al., 1996; Melendez, 1982; Morton, 1981). Results in this study suggest the
antimicrobial action of C. viminalis and related species might be due, in part, to anti-QS
activity.
Q. virginiana and T. bicolor are trees of the Fagaceae and Melastomataceae
respectively. Q. virginiana has a long history of use by Cuban peoples and Native
American tribes as a febrifuge and for dysentery (Moerman, 1998; Morton, 1981),
whereas T. bicolor has been used to treat fevers in the Bahamas (Morton, 1981). As
suggested by this work, traditional use may be related to QS inhibition.
C. hypericifolia (Euphorbiaceae), is used in the treatment of opthamalogical
ailments, diarrhea and other digestive disorders, respiratory conditions, fever, and
gonorrhea. This latex-containing, weedy species is found throughout the Caribbean,
South American, and old world tropics. Interestingly, only the ethanol extract of this
plant exhibited anti-QS activity, suggesting the active compounds to be either less polar
than those found in the other tested plants, or possibly heat labile.
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6.3 Attenuation of Pseudomonas aeruginosa virulence
After displaying promising anti-QS activity against several biomonitor strains
(Chapter 1), six plants from that study were tested against the human opportunistic
pathogen P. aeruginosa.. Relevant to the traditional uses of these plants, P. aeruginosa
may indeed be the causative agent for a number of conditions such as fever, eye and skin
infections, and respiratory ailments (Bodey et al., 1983) (Chapter 1, Figure 1.10).
Additionally,

this

organism

remains

problematic,

especially

in

the

immunocompromised individual, due to its intrinsic and inherent resistance, massive
exotoxin production, and the ability to form biofilms (Hancock & Speert, 2000; Lyczak
et al., 2002). The production of toxins and biofilms is QS controlled (Venturi, 2006), and
thus attenuation of P. aeruginosa virulence should be seen with plant inhibitors of the QS
system.
The active plants from the previous study were thoroughly evaluated for their
effect on a number of virulence factors, QS-gene expression, and QS signal concentration
(Chapter 3; (Adonizio et al., 2008b)). Effect on LasA production was gauged via
staphylolytic assay, while LasB inhibition was visualized with chromophore-linked
elastin. Pyoverdin concentrations in the supernatant were recorded based on florescence,
and biofilm formation was assessed in PVC microtiter plates. Additionally, the direct
effect on the main QS system was followed using ONPG visualization of lacZ-QS gene
fusion products. AHL signal concentration was also monitored by LC-MS.
The most effective plants, C. erectus, B. buceras, and C. viminalis, caused
significant inhibition of LasA protease, LasB elastase, pyoverdin production, and biofilm
formation (Chapter 3, Table 3.1). Additionally, each plant demonstrated a distinct profile
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of effect on the las and rhl QS genes and their respective signaling molecules (Chapter 3,
Table 3.2), suggesting different mechanisms responsible for efficacy. Furthermore,
extracts of all plants caused inhibition of QS genes and QS-controlled factors without a
significant decrease in cell density. This suggests an inhibition of quorum sensing rather
than a bactericidal effect.
At this point, there is not sufficient data to pinpoint the exact method of QS
inhibition, however a partial mechanistic picture can be drafted for the top three extracts
based on the results in Chapter 3. C. erectus and B. buceras exhibit a similar pattern of
QS system repression. Both show a significant decrease in expression of all four QS
genes tested (Table 3.2). Both extracts also decrease levels of the signaling molecules
OdDHL and BHL, though only B. buceras does so significantly. With a few exceptions,
both extracts also markedly reduce virulence and biofilm formation (Table 3.1). This
general effect may suggest that the components from these plant extracts could affect a
global QS regulator such as GacA (Figure 6.1).
Additional information on the ellagitannins purified from C. erectus (Chapter 5)
suggests that vescalagin may have a more direct effect on the rhl system as it
significantly reduces both rhlI expression and BHL concentration (Table 5.2). Since
neither of the purified ellagitannins had an effect on pyoverdin, there may be a yet
unidentified compound in C. erectus responsible for its attenuation. However, the
unresolved effect of the purified ellagitannins on rhlR may suggest regulation of
pyoverdin by factors outside of the QS system.
C. viminalis also generates an interesting profile of effect on P. aeruginosa. It
shows a pronounced reduction of OdDHL, however no reduction of BHL (Chapter 3,
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Table 3.2). This could suggest a more direct inhibition of LasI, lifting the negative
regulation of OdDHL on RhlR thus activating a feedback loop to increase production of
BHL (Figure 6.1). The most significant decreases in lasI and lasR expressions were
found with C. viminalis (Table 3.2). As expected, the LasA and elastase activities are
also significantly decreased (Table 3.1).

Figure 6.1 QS pathway of P. aeruginosa (modified from Van Delden and Iglweski 1999)
and possible activity of crude extracts and purified vescalagin. GacA is a global regulator
of QS, LasI is a synthetase which produces the signal OdDHL, LasR is the regulator
which binds OdDHL. RhlI synthetase produces BHL which binds to its cognate receptor
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RhlR. Black arrows indicate known regulatory patheays. Grey arrows indicate possible
mechanisms of action of C. erectus, B. buceras, C. viminalis, and vescalagin.

6.4 Inhibition of P. aeruginosa virulence in a nematode model
Results from in vitro studies, although significant, are often too far removed from
a live host to suggest any clinical relevance. Thus, a Caenorhabditis elegans system was
chosen to model the effect of the plant extracts on a P. aeruginosa infection (Darby et al.,
1999; Tan & Ausubel, 2000). Identical virulence factors are responsible for pathogenicity
in both a human and nematode host (Rahme et al., 1995; Tan et al., 1999a), and in both
cases virulence is QS-mediated. Thus, addition of plant compounds that have an effect on
P. aeruginosa QS, should therefore attenuate bacterial virulence and subsequent death of
C. elegans (Chapter 4; (Adonizio et al., 2008a)).
Aqueous extracts of C. erectus, C. viminalis, and B. buceras were evaluated in
both toxin-based and infection-based assays with P. aeruginosa strains PAO1 and PA14.
Toxin based assays such as paralysis or “Fast-killing” of follow P. aeruginosa killing of
C. elegans due to the absorption of virulence factors or cyanide toxicity. “Slow-killing”
assays, report death via ingestion of the bacteria and subsequent infection (MahajanMiklos et al., 1999; Tan et al., 1999a; Tan et al., 1999b).
The tested plant extracts prevented mortality via gut infection in almost 60% of
the worms, and caused a 50-90% reduction in death from toxin production (Figure 4.1).
Although there was an unexplored possibility that the plants augmented the immune
system of the nematode thus preventing massive infection, it is much more likely to be an
anti-QS effect given the previous in vitro results (Chapter 3; (Adonizio et al., 2008b)).
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Additionally, all extracts inhibited nematode death by P. aeruginosa without host
toxicity, indicating their potential for further development as anti-infectives.

6.5 Ellagitannins are responsible for anti-QS activity
After establishing anti-QS activity of the plant extracts on P. aeruginosa both in
vitro and in a live animal model, one extract (C. erectus) was chosen for isolation of
active compounds. The isolation procedure was largely guided by anti-QS bioassays
using P. aeruginosa lacZ-fusion strains discussed in Chapter 3.
Two stereoisomeric ellagitannins, vescalagin and castalagin were isolated from
the aqueous extract of C. erectus using low-pressure column chromatography and HPLC.
Structures were confirmed via mass spectrometry, proton-, and 2D-NMR spectroscopy.
Both ellagitannins were shown to decrease AHL production, QS gene expression,
and virulence factor production in P. aeruginosa (Chapter 5, Table 5.1 & 5.2). This is the
not only the first report of these compounds being isolated from C. erectus, but also the
first documentation of their activity on the QS system of P. aeruginosa.
An interesting retrospective is that all active plants from the first study belong to
plant families known to contain ellagitannins (Chapter 5). This would suggest at least
some of the active compounds to be ellagitannins in these species. The Combretaceae,
Fagaceae, Melastomataceae, Euphorbiaceae, and Myrtaceae families all produce Cglycosidic tannins based on ellagic acid. In addition, ellagic acid itself has been shown to
possess anti-QS activity (Huber et al., 2004), further corroborating the findings in this
study
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6.6 Future directions
This work demonstrated a number of medicinally-used plants to have anti-QS
activity,

most

notably

Conocarpus

erectus

(Combretaceae),

(Combretaceae), and Callistemon viminalis (Myrtaceae).

Bucida

buceras

These plants effectively

inhibited QS-gene expression, signal concentration, and virulence factors in P.
aeruginosa. Additionally, the attenuation of morbidity and mortality in a nematode
model without toxicity validates past and potential future therapeutic use.
Ellagitannins were elucidated as the active compounds in C. erectus, and
displayed anti-QS activity against P. aeruginosa (Chapter 5). It would be valuable to
assess the dose-dependance of these compounds and to test their ability to prevent
infection in a nematode model system (Chapter 4; (Adonizio et al., 2008a)) and perhaps
the murine model developed for halogenated furanones (Wu et al., 2004).
The medicinal plants B. buceras and C. viminalis also hold very promising antiQS activity and their chemistry should be explored. Since B. buceras is in the same
family as C. erectus, its activity is potentially due to similar ellagitannins. Tannins in the
Myrtaceae however are considerably different (Okuda et al., 1982; Yoshida et al., 2007),
and may or may not be the responsible compounds in this species.
Future research into the naturally-occurring ellagitannins is also quite valuable.
Ellagitannin containing fruits such as raspberry, blackberry blueberry, and grape have
been popularized as nutraceuticals for their anti-oxidant and heart-health benefits (Espin
et al., 2007). However, a recent study shows these fruits to have anti-QS activity in vitro
(Vattem et al., 2007). In light of the research contained herein, this activity is likely due
to their high ellagitannin content. The variability of ellagic and other types of tannins in
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the plant kingdom, combined with numerous opportunities for chemical modification,
provides us a new resource with indispensable therapeutic potential. Subtle changes
made to the structure of these tannins such as the addition or removal of functional
groups could increase their efficacy. The anti-QS activity of this class of compounds is
relevant not only in the attenuation of Pseudomonas infections, but in the treatment of
other bacterial diseases as well.
Although a few potential modes of action have been proposed in this dissertation,
exact mechanistic interactions with the QS system should at some point be resolved for
ellagitannins. Tannins have been shown to interact with the bacterial cell membrane
suggesting the ability of these compounds to cross the cell wall (Scalbert, 1991). Specific
localization and protein binding studies could be used to gauge potential interactions with
individual components of the QS system. Finally, the continued screening of medicinal
plants and libraries for anti-QS activity is also of the utmost importance, as many new
compounds await discovery.
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APPENDIX
NMR STRUCTURAL DATA FOR ISOLATED ELLAGITANNINS

Vescalagin:
1

H NMR (600 MHz; D2O acidified with d-TFA): δ 4.20 [d, 1H, J=12.7 Hz, H-6], 4.73
[dd, 1H, J=1.0, 6.8 Hz, H-3], 4.90 [dd, 1H, J=2.4, 13.2 Hz, H-6], 4.95 [d, 1H, J=2.1 Hz,
H-1], 5.15 [t, 1H, J=7.1 Hz, H-4], 5.36 [t, 1H, J=1.6 Hz, H-2], 5.55 [d, 1H, J=7.3 Hz, H5], 6.73 [s, 1H, H-2(IV)], 6.86 [s, 1H, H-6(V)], 6.95 [s, 1H, H-6(III)]
1

H NMR (600 MHz; [D6]-acetone:D2O 8:2): δ 4.01 [d, 1H, J=12.6 Hz, H-6], 4.48 [d, 1H,
J=7.3 Hz, H-3], 4.83 [d, 1H, J=2.1 Hz, H-1], 4.95 [dd, 1H, J=1.9, 13.1 Hz, H-6], 5.11 [t,
1H, J=7.3 Hz, H-4], 5.20 [brs, 1H, H-2], 5.55 [d, 1H, J=7.5 Hz, H-5], 6.57 [s, 1H], 6.72
[s, 1H], 6.73 [s, 1H]
13

C NMR (151 MHz; D2O acidified with d-TFA; partial assignment based on HMQC
and HMBC correlations): δ 63.8 [C-1], 65.5 [C-6], 68.2 [C-3], 68.7 [C-4], 70.9 [C-5],
77.3 [C-2], 107.0 [C-2(IV)], 108.8 [C-6(V)], 109.3 [C-6(III)], 113.5 [C-2(III)], 113.5 [C6(IV)], 115.2 [C-2(V)], 117.1 [C-2(I)], 123.3 [C-1(I)], 135.1 [C-4(IV)], 136.3 [C-4(III)],
136.7 [C-4(V)], 144.4 [C-3(I)], 144.7 [C-5(V)], 145.2 [C-5(III)], 165.9 [C-7(II)], 166.3
[C-7(I)], 167.2 [C-7(V)], 167.6 [C-7(III)], 170.3 [C-7(IV)]

Castalagin:
1

H NMR (600 MHz; D2O acidified with d-TFA): δ 4.24 [d, 1H, J=12.8 Hz, H-6], 5.00
[dd, 1H, J=2.1, 12.7 Hz, H-6], 5.10 [d, 1H, J=6.4 Hz, H-3], 5.16 [t, 1H, J=7.1 Hz, H-2],
5.21 [d, 1H, J=4.7 Hz, H-4], 5.59 [d, 1H, J=7.3 Hz, H-5], 5.78 [d, 1H, J=4.8 Hz, H-1],
6.80 [s, 1H], 6.86 [s, 1H], 7.00 [s, 1H]
1

H NMR (600 MHz; [D6]-acetone:D2O 8:2): δ 4.00 [d, 1H, J=12.6 Hz, H-6], 4.96 [dd,
1H, J=1.0, 7.1 Hz, H-3], 4.98 [dd, 1H, J=1.4, 4.7 Hz, H-2], 5.00 [d, 1H, J=2.6, 13.0 Hz,
H-6], 5.15 [t, 1H, J=7.3 Hz, H-4], 5.53 [dd, 1H, 1.1, J=7.5 Hz, H-5], 5.66 [d, 1H, J=4.7
Hz, H-1], 6.60 [s, 1H, H-2(IV)], 6.74 [s, 1H, H-6(III)], 6.76 [s, 1H, H-6(V)]
13

C NMR (151 MHz; [D6]-acetone:D2O 8:2; partial assignment based on HMQC and
HMBC correlations): δ 65.1 [C-6], 66.0 [C-3], 66.8 [C-1], 69.0 [C-4], 70.9 [C-5], 73.8
[C-2], 107.3 [C-2(IV)], 108.0 [C-6(V)], 108.5 [C-6(III)], 114.2 [C-2(III)], 114.8 [C6(IV)], 115.7 [C-2(I)], 115.7 [C-2(V)], 121.7 [C-1(I)], 135.8 [C-4(IV)], 136.3 [C-4(III)],
136.4 [C-4(V)], 143.3 [C-3(I)], 145.0 [C-5(V)], 145.2 [C-5(III)], 145.2 [C-3(IV)], 164.5
[C-7(I)], 165.4 [C-7(II)], 166.5 [C-7(V)], 167.1 [C-7(III)], 169.1 [C-7(IV)]
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